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Abstract

PROTEIN KINASE C MEDIATED INHIBITION OF KIR3.2 (GIRK2) ACTIVITY AND
ITS MOLECULAR DETERMINANTS
By Scott Kellam Adney, B.Sc.
A dissertation submitted in partial fulfillment of the requirements for the degree of
Doctor of Philosophy at Virginia Commonwealth University.
Virginia Commonwealth University, 2013
Dissertation Director: Diomedes E. Logothetis, Ph.D.
Professor and Chair, Department of Physiology and Biophysics

Inwardly rectifying potassium (Kir) channels are critically important for regulating resting
membrane potential in excitable cells, a job underscored by the severe pathophysiology
associated with channel dysfunction. While all Kir channels require the activating lipid PIP2,
many of these channels have diverse modulatory factors that couple to PIP 2-dependent gating.
Channels in the Kir3 (GIRK) family, in particular, have several co-activating elements, including
G-protein  subunits, ethanol, and sodium. During stimulation of Gq-coupled receptors,
downstream activation of Protein Kinase C can phosphorylate and inhibit Kir3 channels, yet the
mechanism of inhibition and phosphorylation sites are incompletely understood. We took a
combined experimental and computational approach using neuronal Kir3.2 to investigate how
phosphorylation at a putative PKC site identified in Kir3.1/3.4 could lead to channel inhibition.
Kir3.2 inhibition was found to depend on the phosphorylation state of Ser-196, although
mutagenesis data suggest it functions as an allosteric regulator of PKC inhibition. MD
simulations identified a molecular switch whereby phosphorylation of Ser-196 recruits a critical
gating residue, Arg-201, away from the sodium coordination site Asp-228. Neutralization of

xi

Ser-196 or Arg-201 resulted in less active channels which exhibited increased sensitivity to PKC
inhibition. Additionally the interplay of PIP2 and PKC inhibition was examined in depth using
homomeric Kir3.2, revealing that increases in channel-PIP2 interactions limit sensitivity to PKC
inhibition, whereas low levels of PIP2 increase PKC sensitivity. Neutralization of Ser-196
uncoupled PKC inhibition from this PIP2 dependence. These studies suggest a model whereby
PKC inhibition can occur along PIP2-dependent and PIP2-independent pathways, depending on
the phosphorylation state of Ser-196.

xii

Chapter 1: BACKGROUND

1.1.

Introduction
Inward rectifier potassium (Kir) channels allow precise control of cellular excitability by

primarily passing hyperpolarizing currents when the cellular membrane potential is more
positive than the equilibrium potential for potassium ions. The inward rectifier family includes
channels that are constitutively active (e.g. Kir1, Kir2), as well as channels gated by G-proteins
(Kir3), adenosine triphosphate (ATP) (Kir6), and hydrogen ions (Kir4) (Hibino et al., 2010).
While constitutively active channels are thought to be refractive to modulation, channels gated
by cytoplasmic factors have multiple pathways of activation and inhibition. The focus of this
dissertation is on elucidating the molecular mechanism of one specific pathway, PKC-mediated
inhibition of G-protein activated inward rectifier potassium channels (GIRKs or Kir3s).
The Kir3 family can be activated by stimulation of G-protein Coupled Receptors
(GPCRs) of the pertussis toxin-sensitive (PTX) Gi/o family. When activated by a bound ligand,
the GPCR stimulates hydrolysis of G-GTP to GGDP, leading to dissociation of G from
G. G subunits then directly bind the Kir3 channel to activate it (Hibino et al., 2010;
Logothetis et al., 1987; Luscher and Slesinger 2010). There are two presumed pathways of
inhibiting channel activity, converging at the Gq-coupled pathway. Activation of Gq-coupled
GPCRs results in hydrolysis of phosphatidyl-inositol 4,5-bisphosphate (PIP2), forming inositol
1,4,5-trisphosphate (IP3) and diacylglycerol (DAG). PIP2 itself is a coactivator of Kir3 channels,
1

and is absolutely essential for channel activity (Huang et al., 1998; Zhang et al., 1999).
Reduction of membrane PIP2 levels by Gq activation should therefore directly inhibit Kir3
current. However, Gq-coupled receptor activation also increases DAG levels, a potent activator
of Protein Kinase C (PKC). PKC activation presents a second means of channel control by
inhibiting the Kir3 channel (Keselman et al., 2007; Mao et al., 2004; Stevens et al., 1999). Since
PIP2 is an essential activator for Kir channels, we hypothesize that PKC-mediated
phosphorylation inhibits channel activity by reducing its affinity for PIP2, in effect changing the
level of PIP2 the channel can sense.
1.2.

Inward Rectifier Kir channels: Classification and Physiological Roles
The storied history of inward rectifier channels begins with their discovery as an oddly-

behaving potassium-selective conductance in skeletal muscle by Bernard Katz in 1949. Unlike
the classic voltage-activated delayed rectifier currents from squid axons, this current had the
peculiar characteristic of preferentially passing current at potentials negative to the potassium
equilibrium potential, EK. This results in currents that are predominantly inward rather than
outward, such that the channels can function like molecular one-way diodes or valves. The
phenomenon of inward rectification was found to primarily result from blockade by intracellular
cations (Mg2+) and positively charged polyamines (e.g. spermine). Strongly rectifying potassium
channels (called Kir channel for inwardly rectifying K+) are thought to be important in
maintaining resting potentials near EK, but do not interfere with normal cellular excitability due
to automatic current shut-off at potentials above EK (Hibino et al., 2010).
With the rapid progress of the molecular age, Kir channel genes were identified and
cloned, allowing expression of the encoded genes in isolated, heterologous systems. The Kir
channels are classified according to channel structure and homology, and separated into seven
2

Kir subfamilies, Kir1 thru Kir7, with a channel phylogenetic tree presented in Figure 1.1A. The
membrane topology of these channels has historically been inferred from hydropathy plots based
on amino acid sequences, although now multiple X-ray crystallographic structures exist. All Kir
channels possess a transmembrane domain and a cytoplasmic domain, whereby the
transmembrane domain is composed of two helices, M1 and M2, with a pore helix interposed.
The channel topology, diagrammed in Figure 1.1B, resembles the voltage-gated potassium
channel (Kv) superfamily, where the M1 (or TM1) and M2 (or TM2) helices correspond to S5
(or TM5) and S6 (or TM6) helices in Kv channels.
The Kir1 subfamily is composed of a single member in humans, Kir1.1, also known as
ROMK1 for Rat Outer Medullary K+, referring to the tissue of cloning origin. Kir1.1 channels
are expressed primarily in renal tissue, and have importance in potassium recycling in the thick
ascending limb (TAL) of the loop of Henle as well as the cortical collecting duct (CCD).
Although still inwardly rectifying, Kir1.1 channels have comparatively weak rectification
(Hibino et al., 2010).
The Kir2 (IRK) subfamily is composed of Kir2.1-2.4, termed classical inward rectifiers
owing to strong rectification and a relative lack of cellular modulation. Kir2.1 (IRK1) in
particular has a critical role in shaping the late repolarization phase of the cardiac action
potential, with predominant expression in ventricular myocytes (Hibino et al., 2010).
G-protein  subunits directly bind and activate members of the Kir3 family, also called
GIRK for G-protein activated inward rectifier K+ channel. The G subunits are released from
the pertussis toxin-sensitive Gi/o class of G-protein coupled receptors. Tissue-specific Kir3
channels are formed by heterotetrameric assembly, with Kir3.1/3.4 dominating in cardiac cells
and Kir3.1/3.2 primarily expressed in neurons. Kir3.1/3.4 channels form the well-documented
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IK,Ach current in pacemaker and atrial myocytes; they are activated by vagal stimulation, when
acetylcholine released from nerve terminals binds the M2 muscarinic receptor and frees Gto
bind and activate the channel. Activation of Kir3.1/3.4 hyperpolarizes atrial myocytes, resulting
in shortened action potential duration and increased refractory period, effectively reducing heart
rate. Neuronal Kir3.1/3.2 channels are responsible for slow inhibitory synaptic potentials, due to
stimulation of Gi/o-coupled receptors like GABAB (Gamma-amino butyric acid receptor B), a
process resulting in G-protein mediated hyperpolarization. All Kir3 channels are activated by
alcohols, and may be involved in neuronal responses to alcoholism (Hibino et al., 2010; Luscher
and Slesinger 2010).
Kir4.1 assembles in a heterotetrameric complex with Kir5.1, and is inhibited by
intracellular acidification. Evidence of homomeric Kir4.1 also exists, but Kir5.1 does not form
functional homomeric channels. Heteromeric assembly seems to affect sensitivity to
acidification and increases rectification. Kir4.1 is expressed in glial cells of the central nervous
system (CNS), where it is thought to regulate potassium recycling. Kir4.1/5.1 channels are also
thought to function as CO2 sensing elements in the brainstem. Knockout models of Kir4.1
indicate that this channel is important in oligodendrocyte function and myelination (Hibino et al.,
2010).
Kir6.1 and Kir6.2 form the ATP-sensitive Kir channel subfamily, with inhibition by ATP
and activation by the dinucleotide adenosine diphosphate (ADP). Kir6.1 and Kir6.2 form
octameric complexes with SUR subunits, named for binding to the sulfonylurea class of drugs.
Kir6.1 is primarily expressed in cardiac tissue, specifically in the coronary artery and
endothelium. Kir6.2 is critically involved in glucose-induced insulin release, with primary
expression in pancreatic beta cells. Activation of glycolytic pathways increases intracellular
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ATP, which inhibits the Kir6.2/SUR complex and depolarizes the beta cell, activating voltagegated calcium channels, which in turn induce insulin release (Hibino et al., 2010).
Kir7.1 channels are thought to function primarily in potassium transport, with high
expression profiles in the choroid plexus, a structure responsible for cerebrospinal fluid
secretion, and the retinal pigment epithelium (Hibino et al., 2010). These channels have much
lower conductance compared to other Kir channels, ~50 fS, due to a unique methionine residue
in the pore region. When mutated to an arginine, the residue in all other Kir channels at the
homologous position, Kir7.1 currents display increased conductance (Krapivinsky et al., 1998).
1.3.

Knockout models in GIRK channels: Insight into Physiology
Kir3 channel knockouts have shown the diverse impact that these channels have on heart

and brain function, primarily. Both Kir3.1 and Kir3.4 knockout mice have reduced carbacholmediated inward currents in atrial myocytes, consistent with elimination of IK,Ach (Bettahi et al.,
2002). Stimulation of pathways leading to lowering of heart rate, like agonism of alpha-1
adrenergic or A1 adenosine receptors, led to a blunted reduction in heart rate in both knockouts.
Specific knockouts of Kir3.2 and Kir3.3 have demonstrated a role for functional channels in the
brain, especially in drug addiction and pain perception. In locus ceruleus neurons, the opioid
met-enkephalin evokes a hyperpolarization due to activation of an outward potassium current.
Kir3.2 knockouts have a reduction in opioid-induced hyperpolarization, but display negligible
responses in the Kir3.2/3.3 double knockout. These results imply a role for Kir3.2/3.3
heteromers in opioid hyperpolarization in the locus ceruleus (Torrecilla et al., 2002).
There is also evidence for the existence of homotetramers of Kir3.2 in the mammalian brain,
specifically in the substantia nigra pars compacta (SNc). Three splice variants of Kir3.2 exist,
termed Kir3.2a-c. Kir3.2c contains an additional PDZ-binding domain at the distal C-terminus
5

not present in Kir3.2a or Kir3.2b. This domain is likely responsible for membrane targeting of
Kir3.2c and its heteromeric partners (Luscher and Slesinger 2010). In one example of
homomeric function, two splice variants, Kir3.2a and Kir3.2c, colocalize in the mouse SNc, but
without evidence of Kir3.1 expression (Inanobe et al., 1999). Human Kir3.2 differs from other
mammalian genes by having a single product, which is closest to the Kir3.2c (sometimes called
GIRK2A-1) isoform.
1.4.

Kir channels gone haywire: Relevance to Disease
The ubiquitous and critical role of inward rectifier channels is underscored by the vast

repercussions that dysregulation of these channels has on human disease. Notably, multiple
channels including Kir1.1, Kir2.1, Kir4.1, Kir6.1, Kir6.2, and Kir7.1 have been shown to have
genetic mutations resulting in multi-organ disorders with a variety of pathologies. Antenatal
Barrter Syndrome Type II, characterized by hypokalemia, metabolic alkalosis, and moderate to
severe low blood pressure, is caused by a loss of function mutation in Kir1.1 (ROMK1)
channels, encoded by the gene KCNJ1. Antenatal Barrter Syndrome mutations in the ROMK1
channel produce their effects by a loss of potassium current in the thick ascending limb (TAL) of
the nephron (Figure 1.2) (Simon et al., 1996). This potassium channel normally sends
reabsorbed potassium back to the tubule lumen, establishing a high enough luminal potassium
concentration to support Na-K-2Cl cotransporter function. Mutations in the coding region of
KCNJ1 can affect synthesis, trafficking (Schwalbe et al., 1998), and even PIP2 activation of the
channel (Lopes et al., 2002), leading to a reduction of potassium reuptake.
Andersen-Tawil syndrome (ATS), a multi-organ disorder presenting with dysmorphic
features, hypokalemic periodic paralysis, and ventricular arrhythmia, results from mutations in
the KCNJ2 gene encoding the Kir2.1 channel (Figure 1.2). Like Barrter Syndrome, many of the
6

mutations found in ATS can affect channel trafficking or interaction with PIP2 (Donaldson et al.,
2003; Lopes et al., 2002). Due to the importance of Kir2.1 in late repolarization of the
ventricular action potential, defects in Kir2.1 function often manifest as a prolonged QT interval.
Dysregulation of Kir4.1 (encoded by KCNJ10) results in SESAME Syndrome, a multisymptom, multi-organ disorder that results in seizures, sensorineural deafness, ataxia, mental
retardation, and electrolyte imbalance (Scholl et al., 2009). Loss of function of Kir4.1 in CNS
glial cells and marginal cells of the inner ear can account for many of the phenotypes in
SESAME Syndrome (Figure 1.2). Kir4.1 additionally is expressed in several locations in the
nephron, such that dysfunction of these channels probably contributes to electrolyte imbalance.
Diseases affecting the eye are associated with mutations in Kir7.1 (encoded by KCNJ13),
highlighting its importance in retinal pigment epithelium (Figure 1.2). Snowflake vitreoretinal
degeneration (SVD) can arise from a point mutation resulting in the R162W missense mutation,
in a putative PIP2-binding region. Kir7.1 channels with this mutation lose potassium selectivity,
which is notable in that the mutation is at the membrane-cytoplasmic interface, rather than in the
selectivity filter (Hejtmancik et al., 2008). Two mutations of Kir7.1 causing Leber congenital
amaurosis have been reported, with one nonsense mutation chopping off the C-terminal domain
entirely (Arg166Stop), and another resulting from a cytoplasmic mutant (L241P) (Sergouniotis et
al., 2011).
The KCNJ11 gene encodes Kir6.2 (KATP), a potassium channel expressed in pancreatic 
cells that is inhibited by increases in intracellular ATP, and thus is critical for depolarizing 
cells to allow glucose-induced insulin release. Kir6.2 forms an octameric complex with its
binding partner, the SUR1 subunit, target of sulfonylurea drugs used in diabetes treatment. The
homeostatic importance of the Kir6.2 channel becomes clear since either loss of function or gain
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of function phenotypes can be deleterious. Loss of function mutants typically result in
hyperinsulinemic hypoglycemia due to unopposed depolarization in the  cell, activating
voltage-gated calcium channels. Conversely, gain of function or activating mutations generally
lead to a neonatal diabetes phenotype, as expected with reduced glucose-induced insulin release
(Figure 1.2). Kir6.2 also has importance in the glucose-sensing mechanisms of brain and
skeletal muscle, and the closely related Kir6.1 protects against ischemia in myocardium (Pattnaik
et al., 2012).
In the Kir3 (GIRK) channel family, point mutations causing disorders are rare, although
mutations altering potassium selectivity have been described. Multiple mutations in KCNJ5,
which encodes Kir3.4, have been described in aldosterone-producing adenomas. One particular
mutation, T158A, near the selectivity filter, is associated with familial hyperaldosteronism type
III, presumably due to persistent depolarization in the adrenal gland and subsequent calciuminduced aldosterone release (Choi et al., 2011). Another mutation, correlating with the
predominant expression of Kir3.4 in the heart, results in a variant of Long QT syndrome. This
mutant (G387R) was described to produce a loss-of-function phenotype on IK,Ach function in the
heart, thus resulting in prolonged depolarization (Yang et al., 2010).
A Kir3.2 mutation naturally occurring in mice, known as weaver, is caused by loss of
potassium selectivity, and significant neuronal loss in the cerebellum and substantia nigra occurs
due to nonselective cation permeation in these mutant channels (Harkins and Fox 2002;
Slesinger et al., 1996). No reported mutations in Kir3.2, encoded by the KCNJ6 gene, are
associated with human disease so far. However, the KCNJ6 gene is located on the distal arm of
chromosome 21, specifically at 21q22.1, and is thought to be relevant in Down Syndrome,
caused by trisomy of chromosome 21. Down Syndrome can be caused by a third copy of a
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nominal portion of genes from chromosome 21, the so-called Down Syndrome Critical Region
(DSCR). This region encompasses 21q22.1-22.3, in which the KCNJ6 gene is contained. In
fact, a recent study by Cooper et al. demonstrated that selective trisomy of Kir3.2 in a mouse
model partially recapitulates Down Syndrome phenotypes, manifesting as deficits in fearconditioned memory and altered synaptic plasticity (Cooper et al., 2012).
Clearly, Kir channel genes fulfill diverse roles in physiology, and disease-causing
mutations can result in widespread dysfunction. In several of the above-mentioned diseases,
point mutations can lead to alterations in channel-PIP2 interactions. In the next section, we will
briefly explore the PIP2 dependence of Kir channels and the attempts to identify interacting
residues experimentally.
1.5.

Kir channel gating requires PIP2
PIP2 composes ~1% of plasma membrane anionic phospholipids, and is by far the most

abundant phosphoinositide at the cellular membrane. It can be interconverted into seven
different species by various membrane-bound enzymes, summarized in Figure 1.3.
Wortmannin, a specific phosphatidyl-inositol 3-kinase (PI3K) inhibitor at nanomolar
concentrations, is also used at high micromolar concentrations to inhibit phosphatidyl-inositol 4kinase (PI4K), reducing the available pool of PI4P (phosphatidyl-inositol 4-phosphate) for
conversion into PIP2 by PIP5K (phosphatidyl-inositol phosphate 5-kinase). PIP2 is best known
in its role as a precursor lipid for formation of the products DAG and IP 3 after PLC activation.
DAG is a specific activator of PKC, while IP3 acts on the IP3 receptor to raise cytosolic calcium
from endoplasmic reticulum (ER) stores, which can further activate calcium-dependent PKCs.
In the last few decades, plasma membrane PIP2 has gained new appreciation as a lipid
modulator of several ion channels and transporters, of which the list is enormous and continually
9

expanding (Logothetis et al., 2010). Beginning in 1996, Hilgemann and Ball discovered that the
activity of sodium/calcium exchange transporters and KATP channels can be directly stimulated
by exogenous PIP2. Furthermore, generation of PIP2 is the reason why application of
hydrolyzable ATP to excised patches restores channel currents (Hilgemann and Ball 1996).
Soon after, other eukaryotic Kir channels were shown to be activated by PIP2 (Huang et al.,
1998; Sui et al., 1998), although with different affinities (Zhang et al., 1999) and
stereospecificity (Rohacs et al., 2003).
Progress was later made in understanding the electrostatic nature of interactions between
Kir channels and PIP2. Neutralization scanning mutagenesis of arginines and lysines to
glutamine and cysteine lowered whole-cell currents and reduced apparent PIP2 binding affinity in
some key conserved regions (Lopes et al., 2002). Furthermore, incorporation of charge at
specific cysteine mutants via sulfhydryl modifying reagents allowed the identification of residues
interacting via electrostatic means. Residues identified by this scan are bolded and marked in
blue in an alignment of Kir channels, relative to phosphorylation sites which are boxed and
marked in green (Figure 1.4). Numerous positively charged residues were implicated in
channel-PIP2 electrostatic interactions, which could later be mapped onto channel homology
models. These maps identified a hotspot for PIP2-sensitive residues at the proximal N-terminus
and C-terminus, including a region known as the CD-loop. Since assessing channel-PIP2
interactions relied on functional assays of channel activity, it was difficult to discern if specific
residue interactions were direct or mediated via allosteric interactions. Still, PIP 2 is now
regarded as a necessary cofactor in Kir channels, and channel activity is subject to alterations in
PIP2 levels with cellular signaling pathways.
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Equally important, however, are the subtle changes in Kir channel function associated
with phosphorylation. Phosphorylation of proteins, the tagging of amino acid residues by the
highly negative phosphate anion, is a well-recognized mode of cellular signaling. Some 10,000
proteins, ~30% of the available genes in the human genome, are thought to contain phosphate
covalently bound to serine, threonine, or tyrosine residues (Cohen 2002). In addition to having
diverse effects on channel synthesis, plasma membrane trafficking, and expression,
phosphorylation can mediate nearly instantaneous effects on Kir channel gating, although the
molecular mechanism remains elusive. One such phosphorylation pathway concerns the PKC
inhibition of Kir channels coupled to Substance P stimulation.
1.6.

Regulation of Neuronal GIRKs: excitation of neurons by Substance P
Neuronal G-protein activated inward rectifier (GIRK) currents are critical determinants of

cellular excitability. Activation of these channels is well-characterized to be a direct interaction
of G subunits with the channel, as a result of G-protein coupled receptor activation of the Gi/o
family. The inhibitory pathway of these channels has historically gained appreciation as well. In
multiple neurons, the undecapeptide Substance P (SP) was shown to induce a slow excitatory
postsynaptic potential, resulting in increased neuronal excitability. Examination of the excitatory
mechanism in voltage-clamp mode of globus pallidus neurons revealed the suppression of an
inward rectifier current (Figure 1.5A-B). The current inhibited by Substance P was more
prominent at hyperpolarizing potentials, and the reversal potential of the inward current shifted
according to the equilibrium potential for potassium, EK (Figure 1.5 C-D). These results
indicated that the channel involved was likely an inward rectifier, conducting primarily
potassium ions (Stanfield et al., 1985).
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In cultured neurons of the nucleus basalis, SP also induced downregulation of an
inwardly rectifying potassium current. This inhibition was readily reversible except in the
presence of the nonhydrolyzable GTP analogue GTPS, implying G proteins are involved in SPmediated effects. The Substance P mechanism of action was also shown to be insensitive to
pertussis toxin (PTX), in stark contrast to the well-recognized PTX-dependence of the
stimulation of G-protein activated inwardly rectifying channels (Nakajima et al., 1988). The SPmediated inhibition of neuronal inward rectifiers was later attributed to PKC activation.
Specifically, incubation with the PKC inhibitor staurosporine or injection with the
pseudosubstrate inhibitor PKC(19-36) significantly reduced the SP-mediated inhibition. At the
single-channel level, in cell-attached patches SP application led to a reversible reduction in
channel open probability (Po). When incubated in the phosphatase inhibitor okadaic acid,
however, the SP-mediated inhibition became irreversible, implying that dephosphorylation was
responsible for reversal of the SP effect (Takano et al., 1995). The single-channel conductance
was measured at ~18 pS, lower than the reported conductance for G-protein activated channels
(~30 pS) (Kofuji et al., 1995). Although the identity of the channel in this study is unknown,
based on location and conductance it is likely to be a member of the Kir2 family, specifically
Kir2.3, which has a reported conductance of ~13 pS (Perier et al., 1994).
Focusing exclusively on G-protein activated channels, Velimirovic et al. found that in rat
brain locus ceruleus neurons, either somatostatin or met-enkephalin perfusion led to an
enhancement of inwardly rectifying currents thru a PTX-sensitive (i.e. Gi/o) G-protein
mechanism. Consequently, Substance P application inhibited currents preactivated with either
somatostatin or met-enkephalin, but this effect was not blocked by PTX. These results indicate
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that in locus ceruleus neurons the underlying molecular effector of Substance P is equivalent to
the channel activated by PTX-sensitive G-proteins (Velimirovic et al., 1995).
While the Substance P effect on locus ceruleus neurons has not been specifically tested
for PKC sensitivity in the same way as the analogous pathway in nucleus basalis neurons,
multiple lines of evidence indicate that neuronal G-protein activated channels are sensitive to
PKC modulation. First, heterologously expressed Kir3.1/3.2 channels, thought to underlie
neuronal G-protein activated currents, were inhibited by phorbol esters which activate PKC, as
well as by coexpressed PKC isoforms (Brown et al., 2005). Secondly, endogenous GABABactivated currents in hippocampal neurons were inhibited by carbachol (a muscarinic receptor
agonist) or the PKC activator PdBu (phorbol dibutyrate), and both effects were blocked by PKC
inhibitors (Sohn et al., 2007a; Sohn et al., 2007b). Similarly, in slice preparations of the ventral
tegmental area (VTA), SP application resulted in inhibition of baclofen-activated (GABAB
receptor agonist) currents, an effect blocked by either the PKC inhibitor Bisindolyl-maleimide I,
the chelation of calcium by BAPTA, the PLC inhibitor U73122, or a NK3 receptor antagonist.
Taken together, these results suggest that in VTA neurons SP acts by stimulating NK3 receptors,
activating PLC, and activating a calcium-dependent PKC isoform, which results in suppression
of a GABAB-activated inward rectifier potassium channel (Xia et al., 2010).
The results outlined above illustrate the immense progress in elucidating the components
involved in inhibition of inward rectifier channels by PKC, but fail to shed light on the molecular
determinants of PKC inhibition, notably the channel residue(s) involved in phosphorylation.
After a brief overview of PKC classification and mechanism of activation, we will survey the
current literature characterizing PKC phosphorylation sites in Kir channels.
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1.7.

Protein Kinase C: A diverse kinase family
The PKC family consists of proteins with structurally related domains involved in kinase

activation, and is divided into conventional, novel, and atypical PKCs. The conventional PKCs
(, I, II, and ) contain C1A and C1B domains that bind the activator DAG and phorbol esters,
as well as a C2 domain responsible for binding phosphatidyl-serine (PtdSer) and calcium. Novel
PKCs (, , , and ) have conventional-like C1 domains but differ in having a C2 domain
without calcium-binding ability. The atypical PKCs (, , ) forgo the C2 domain but have a
unique C1 domain that can bind anionic phospholipids. All kinases in the PKC family share a
highly conserved catalytic domain responsible for phosphorylation of target proteins. Although
PKC enzymes are subject to a high degree of constitutive phosphorylation, translocation to the
membrane and binding to DAG is considered the major activation paradigm (Wu-Zhang and
Newton 2013).
Activation of PKCs can be achieved by phorbol ester drugs which activate PKC in
nanomolar concentrations by hijacking the C1 domain that binds DAG, thus facilitating
membrane translocation. Phorbol 12-myristate,13-acetate (PMA) is one such drug, a potent
tumor promoter which can irreversibly activate PKCs, due to its very low metabolism and high
binding affinity. Experimentally, one can examine direct PKC effects by incubating with
phorbol esters like PMA or PdBu (phorbol dibutyrate), which does not require activation of
upstream PLCs or the resultant PIP2 depletion. Additionally, many enzymes in the PKC family
have scaffolding proteins which assist in membrane binding and localization, termed RACKs
(Receptor for Activated C Kinase). RACKs exist in a macromolecular complex with PKC and
phosphorylation targets, reminiscent of AKAPs (A-kinase anchoring proteins) and PKA (WuZhang and Newton 2013).
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1.8.

Characterizing PKC inhibition in heterologous cell systems
Native cells can provide information about physiologically relevant modulatory

pathways, but discerning the mechanism of these pathways requires studying the respective
channels and receptors in isolation. In the following paragraphs we will examine in depth the
current literature regarding PKC-dependent phosphorylation and specific residues that are
implicated in different Kir channels, with an emphasis on their analogous location in Kir3.2.
In one of the first studies looking at protein kinase modulation of Kir channels, Henry
and colleagues tested Kir1.1, Kir2.1, and Kir2.3 for sensitivity to PKC using Xenopus oocytes.
Perfusion with the PKC activators PMA and PdBu led to an irreversible inhibition of Kir2.3 but
not Kir1.1 or Kir2.1. Inhibition of Kir2.3 was partially blocked by preincubation of the oocytes
with staurosporine, a blocker of multiple PKC isozymes (Henry et al., 1996). Chimeras of
Kir2.3 and Kir2.1 were later employed to identify an N-terminal residue, Thr-53, as necessary
for PKC inhibition (for location see Figure 1.4). Astoundingly, a single point mutant at the
corresponding residue in Kir2.1, I79T, rendered the channel sensitive to PKC inhibition (Zhu et
al., 1999). There has been no biochemical follow-up of this intriguing result, including whether
this threonine residue can be phosphorylated in vivo. The co-crystal of the closely related Kir2.2
with PIP2 shows that the implicated threonine is located right next to a critical PIP 2-binding
motif, the RWR (Figure 1.4). Phosphorylation of this threonine would likely disrupt the
complex electrostatic interaction network between PIP2 and the RWR motif, perhaps leading to
channel inhibition.
The implicated threonine residue is a leucine in all members of the Kir3 family, and thus
not a target of phosphorylation. Nevertheless, Kir3 family members are subject to robust
inhibition by PKC. Kir3.1, Kir3.2, and Kir3.4 homomeric channels are inhibited by PMA
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treatment, as are Kir3.1/3.2 and Kir3.1/3.4 heteromeric channels. The target of phosphorylation
is unclear, although Ser-185/Ser-191 has been suggested to be a substrate for PKC
phosphorylation in Kir3.1/3.4 channels. Mutation of this residue to alanine in homomeric and
heteromeric channels reduced PMA-mediated inhibition. Importantly, this study also
demonstrated direct regulation by a catalytic subunit of PKC in excised patches, where treatment
of Kir3.1/3.4 channels with PKC led to a reduction in NPo (Mao et al., 2004). In atrial
myocytes, native Kir3.1/3.4 channels co-immunoprecipitated with the PKC-specific scaffold
protein RACK1, and PKC treatment of excised myocyte patches led to inhibition of AChactivated Kir currents (Nikolov and Ivanova-Nikolova 2004).
The corresponding residue (Ser-196) was later tested in Kir3.1/3.2 channels in a
heterologous HEK293 expression system. In excised patches, purified PKC reversibly inhibited
Kir3.1/3.2 channels as well as Kir3.1S185A/Kir3.2S196A. Carbachol stimulation of M3
receptors resulted in equivalent inhibition of wildtype and mutant channels in whole-cell mode.
The authors concluded that the residue implicated in Kir3.1/3.4 may not be applicable to
Kir3.1/3.2 channels. Additionally, purified C-termini of Kir3.1 and Kir3.2 were assessed for in
vitro phosphorylation by PKC, but only the Kir3.1 C-terminus led to incorporation of detectable
phosphate (Brown et al., 2005).
Reports of Kir1 (ROMK) inhibition by PKC are scarce and often controversial. PMA
application inhibits native Kir1 channels that form the small-conductance potassium channel
(ISK) on the apical membrane of rat cortical collecting duct cells (CCD) (Wang and Giebisch
1991). In the heterologous Xenopus oocyte system, Zeng et al. showed that PMA does not
inhibit wildtype Kir1.1 channels but can inhibit channels with reduced apparent PIP 2 affinity,
exemplified by the S219A and R188Q mutant channels. This implied a role for reduced channel-
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PIP2 interactions as a final common mediator of PKC inhibition. The authors failed to find a
direct inhibitory effect of applying the catalytic PKC subunit on Kir1.1_S219A channels, in
contrast to what has been reported for Kir3.1/3.4 and Kir3.1/3.2 channels (Brown et al., 2005;
Mao et al., 2004). Instead, they postulated that the inhibition of S219A and R188Q was due to a
PKC-mediated reduction in membrane PIP2 content through an unknown mechanism, rather than
via direct Kir1.1 phosphorylation (Zeng et al., 2003). This notion was challenged in a later
study, however, that looked more directly at membrane PIP2 using a FRET-based reporter assay.
While Gq-coupled M1 stimulation led to a reduction in membrane PIP 2, PMA application did not
(Keselman et al., 2007).
A later study looked at more subtle changes in Kir1.1 function, by analyzing the
intracellular pH dependence of the channel before and after PMA treatment. PMA treatment
induced an alkaline shift of the pKa for inhibition, in effect making the channel more sensitive to
intracellular protons. The authors identified a novel threonine residue (Thr-193) as a potential
substrate for PKC phosphorylation. When mutated to alanine, the PMA effect on intracellular
pH sensitivity was lost. In molecular dynamics (MD) simulations, the distance between
phosphorylated Thr-193 and Arg-188 decreases, and consequently Arg-188 is pulled farther from
the membrane interface. Although PIP2 was not included in the simulations, the authors propose
that Arg-188 is normally interacting with PIP2, and when Thr-193 gets phosphorylated, Arg-188
is pulled away from the PIP2 molecule (Huang et al., 2012). Sequence alignment with other Kir
channels indicates that Thr-193 is unique to Kir1.1, as all other Kir channels do not have a
Ser/Thr at this position. Additionally, this study lacks biochemical characterization of the novel
phosphorylation site. Arg-188 maps to Arg-201 in the Kir3.2 channel, and Ser-219 aligns with
Ser-232 (see Figure 1.4).
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Heteromeric channels of Kir4.1/5.1, a potent cellular sensor of acidification with key
roles in the eye and brainstem, also exhibited inhibition by PKC activators (Rojas et al., 2007).
Kir4.1 homomers were not sensitive to PMA or thymeleatoxin, while Kir4.1/5.1 heteromers were
subject to robust inhibition. This inhibition was not found to rely upon endocytosis of active
channels, but rather a reduction in channel open probability (Po). The authors found that the
purified C-terminal domains of both Kir4.1 and Kir5.1 were subject to phosphorylation by the
catalytically active subunit of PKC, but could not identify the specific sites by mutagenesis
scanning. Interestingly, the mutant Kir5.1_T174D greatly reduced the sensitivity to PKC
inhibition, which was intact in Kir5.1_T174A. This particular residue corresponds to Gln-197 in
Kir3.2, located before the PIP2-binding motif KKR, and is either a neutral Gln or positive
Lys/Arg in all other channels (see Figure 1.4). The authors conclude that this site is not a target
of PKC phosphorylation, but may alter channel function, consistent with its location.
Conversely to the channels examined so far, PKC treatment leads to activation of Kir6.2
(KATP) channels in excised patches, rather than inhibition. This activation seems to rely on
changing the dose-dependence of ATP inhibition, essentially reducing the cooperativity of ATP
binding. In the presence of low levels of ATP, PKC treatment inhibits the channel, with a
crossover of activation/inhibition around 110 M (Light et al., 2000). Phosphorylation of a
single residue, T180, is implicated in this effect, which corresponds to T204 in Kir3.2. Mutation
of this residue to alanine or glutamate abrogated the effect of PKC, and led to a loss of in vitro
phosphorylation in immunoprecipitated Kir6.2 protein. Mutation to either residue also resulted
in an increased open time, such that the authors propose that this residue has importance in
regulating channel gating as well.
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Further complicating matters, an inhibitory effect of PKC phosphorylation of the distal
C-terminus of Kir6.2 has been described, at Ser-372 (Aziz et al., 2012). This residue seems to be
involved in PKC-dependent internalization rather than direct effects on channel gating. A
frequently used construct to study Kir6.2 in isolation rather than as a SUR-containing complex
truncates the channel’s distal 26 residues, called Kir6.2C26. This construct does not include
Ser-372, which partially explains the predominant activating effect of PKC found by Light et al.
Like most other Kir channels tested, PKC phosphorylation of Kir6.1 has been associated
with channel inhibition. Shi et al. identified a distal C-terminus composed of five
phosphorylation sites not found in Kir6.2, which mutation analysis identified as important in
PKC-dependent inhibition (Shi et al., 2008). Mutation of individual serines to alanine reduced
PMA inhibition somewhat, but a channel with all five mutated was rendered completely
insensitive to PMA inhibition. Only one of these serines maps to Kir3.2, at Ser-368 (at the distal
C-terminus, not included in Figure 1.4). The rest are in an arginine rich region unique to Kir6.1.
The last channel examined is Kir7.1, the channel with the very small conductance found
in the retinal pigment epithelium (RPE). The PKC activators OAG and thymeleatoxin inhibit
this channel when expressed in Xenopus oocytes. The mutant S201A significantly reduced the
effect of OAG. Only Kir3.1 in the Kir3 family contains the corresponding serine residue at Ser225, whereas all other Kir3 channels have glutamate at this position (Glu-237 in Kir3.2) (Zhang
et al., 2008).
This survey of PKC phosphorylation of the Kir channel family (summarized in Table 1.1)
indicates that most Kir channels are inhibited by PKC activation, with the exception of reports of
activation in Kir6.2. A study by Du et al. looked at a panel of Kir channels and their response to
PMA inhibition, where the vast majority of channels were inhibited, including Kir6.2.
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Consistently, Kir1.1 and Kir2.1 do not show PMA inhibition, except in cases when channel-PIP2
interactions are decreased (Du et al., 2004). Looking at specific residues implicated in PKC
phosphorylation, these studies identify two principal regions likely to be involved: the proximal
C-terminus near the base of the M2 helix, and the distal C-terminus. Many of these
phosphorylation sites are located nearby residues implicated in PIP2 binding (blue residues in
Figure 1.4), such that negatively charged phosphates could alter the complex electrostatic
network between the Kir channel and PIP2 (Logothetis et al., 2007). We next turn to the
experimental evidence in support of a PIP2 dependence on PKC inhibition in Kir channels.
1.9.

Channel-PIP2 interactions underlie PKC inhibition of Kir3 Channels
All Kir channels require the signaling lipid PIP2 for activation, and decreases in

membrane PIP2 after Gq-coupled PLC stimulation accounts for inhibition in several Kir channels.
In Kir3 channels, some studies have indicated that PKC activation can account for inhibition
from Gq-coupled receptors, such that blockers of PKC attenuate Gq-coupled inhibitory pathways
(Keselman et al., 2007; Stevens et al., 1999). Since Gq-coupled pathways result in both PIP2
depletion and PKC activation, crosstalk between these pathways converging on a mechanism
reducing channel-PIP2 interactions is worth exploring.
The seminal study by Du et al. found that alterations in channel-PIP2 interactions
produced by point mutations could in turn alter sensitivity to PKC inhibition. Kir2.1, which is
normally resistant to inhibition, gained sensitivity with the mutation R312Q (analogous to R324
in Kir3.2). Conversely, the readily inhibited Kir2.3 channel could be rendered insensitive to
PKC by the point mutant I213L (I234 in Kir3.2). Kir3.4* channels also exhibited high
sensitivity to PKC inhibition, which was abrogated by coexpression of G, previously shown to
increase channel-PIP2 interactions. These results implied that increased channel-PIP2
20

interactions, as with Kir2.1, Kir2.3_I213L, and Kir3.4*/G, reduce or abrogate entirely channel
sensitivity to PKC inhibition. Reduced channel-PIP2 interactions, as with Kir2.3,
Kir2.1_R312Q, or Kir3.4* alone, increase sensitivity to PKC inhibition. (Du et al., 2004).
In the Kir3.1/3.4 channel expressed in HEK293 cells, PMA inhibition was partially
blocked by PIP5K overexpression or by dialysis of exogenous PIP2. Wortmannin pretreatment,
which reduces membrane PIP2 levels, led to increased sensitivity to PMA inhibition (Keselman
et al., 2007). Similarly in native hippocampal neurons, PIP2 dialysis prevented PKC inhibition of
baclofen-activated potassium current (Sohn et al., 2007a). In excised patches, PKC treatment of
Kir3.1/3.4 channels resulted in a rightward shift of the dose-dependence of PIP2 activation
(Keselman et al., 2007). These results imply that PKC action inhibits Kir3 channels by reducing
channel-PIP2 interactions, which would be expected to potentiate inhibition caused by PLCmediated PIP2 depletion.
To further explore the idea that phosphorylation can alter channel-PIP2 interactions, we
next turn to PKA regulation of Kir1.1 and Kir3.1/3.4 pathways, a well-studied phosphorylation
paradigm implicated in modulation of channel-PIP2 interactions.
1.10. Mechanistic insight from other phosphorylation pathways: Focus on PKA
The Kir1.1 channel (ROMK1) has been extensively studied for how phosphorylation
affects activity. The channel is activated by cAMP-dependent protein kinase (PKA), and the
functional PKA phosphorylation sites have been mapped using a combination of biochemical
and electrophysiological approaches (Xu et al., 1996). Phosphorylation at S219 and S313 is
generally thought to increase channel open probability (Po). Interestingly, one of the antenatal
Barrter Syndrome loss-of-function mutations is S219R (Simon et al., 1996), which would
abrogate phosphorylation and introduce positive charge at a typically negatively charged site.
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Once activated by PKA, the Kir1.1 channel now has a left-shifted PIP2 apparent affinity,
consistent with PKA phosphorylation increasing channel-PIP2 interactions. Both the S219A and
S313A channel mutants have reduced PIP2 affinity compared to wildtype channel, but the
phosphomimetic mutants (S219D and S313D) also have reduced affinity (Liou et al., 1999). It is
possible, however, that the phosphomimetic aspartate is not able to adequately mimic the
phosphorylated serine. Ser-219 and Ser-313 of Kir1.1 map to Ser-232 and Ser-324 in Kir3.2,
respectively, and are next to PIP2-sensitive residues Arg-230 and Arg-324 (see Figure 1.4).
A recent paper has also characterized potential PKA phosphorylation sites, this time in
Kir3.1/3.4 channels. Kir3.1/3.4 currents expressed in Xenopus oocytes can be potentiated by
injection of cAMP, presumably through a PKA-dependent mechanism. Mutation of Thr-199 in
homomeric Kir3.4* had a profound effect, essentially preventing the PKA-dependent
potentiation by cAMP. Furthermore, Kir3.4 C-terminal peptides with the T199C mutant had
significantly reduced 32P incorporation after PKA treatment compared to control. The equivalent
residue to Thr-199 is present in the crystal structure of Kir3.2 (as Thr-204), but other residues
described in this study are in the distal C-terminus of Kir3.1 and Kir3.4, and not present in the
Kir3.2 structure (Treiber et al., 2013). Even so, a molecular understanding of how
phosphorylation of Thr-199 leads to channel activation is unclear.
In a separate study, Lopes et al. demonstrated that C-terminal peptides of Kir3.1 and
Kir3.4 were subject to in vitro phosphorylation by PKA, and whole-cell currents of Kir3.1/3.4
expressed in Xenopus oocytes were reduced after H89 treatment (a PKA inhibitor). Muscarinic
inhibition of Kir3.1/3.4, a measure of PIP2 sensitivity, was increased after H89 treatment as well,
an effect abolished by heteromeric channels containing putative PKA phosphorylation site
mutations (Kir3.1_S221A or S315A, which map to Kir1.1 PKA sites Ser-219 or Ser-313).
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Finally, PKA treatment of Kir3.1/3.4 in excised patches resulted in a left-shifted dosedependence of PIP2 activation (Lopes et al., 2007). Taken together, these results imply that PKA
phosphorylation of Kir3.1/3.4 results in increased apparent PIP2 affinity, and therefore decreases
sensitivity to Gq-mediated PIP2 depletion. Qualitatively, PKA-mediated increases in PIP2
affinity resemble the case with Kir1.1, but the molecular explanation of how phosphorylation
changes channel-PIP2 interactions is still lacking.
Lee and colleagues sought to gain a molecular understanding of PKA phosphorylation in
the Kir1.1 (ROMK1) channel, at the residue previously shown to be phosphorylated by PKA
(Ser-219). To accomplish this, they combined molecular dynamics simulation studies with
electrophysiology, specifically focusing on intracellular pH-induced gating. Kir1.1 can be
inhibited by decreases in intracellular pH (i.e. acidification) in excised patches, in a manner
dependent on PIP2 affinity. PKA treatment of excised patches can induce a left-ward shift off
the pKa for inhibition, essentially making the channel harder to inhibit. The S219A and S313A
mutants mimicking a non-phosphorylated state have a right-shifted pKa, approximately 7.2. For
structural understanding, the authors first built a homology model based on the KirBac1.1 crystal
structure, then used molecular dynamics simulations to investigate the wildtype and Ser-219
phosphorylated channels. Their simulation results indicate that phosphorylation at Ser-219
recruits the nearby Arg-217 residue, ultimately resulting in the movement of Lys-218 closer to
the membrane. Although the PIP2 molecule is not included in their simulation, the authors
contend that repositioning of Lys-218 should result in a stronger channel-PIP2 interaction near
this residue (Lee et al., 2008). Further understanding is limited by the lack of explicit PIP2 in the
simulation and experimental testing of its results. Still, this is an important first step in
elucidating a structural mechanism for how phosphorylation controls channel gating. In Kir3.2,
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Lys-218 is an asparagine, but the nearby Arg-217 is absolutely conserved in all Kir channels
(Arg-230 in Kir3.2).
Clearly, PKC inhibition and PKA activation present a reversible, powerful means of
controlling channel activity. Evidence points to a mechanism converging on modulation of
channel-PIP2 interactions, but the molecular mechanism of how tagging a specific site with the
negative phosphate leads to alterations in channel-PIP2 interactions is unclear. Part of the answer
to this question may lie in how PIP2 gates a Kir channel, which is explored in the next section.
1.11. A Brief History of Kir Channel Structures
In 1998, a landmark study by MacKinnon’s laboratory, for which he received the Nobel
Prize in Chemistry, produced the first crystal structure of a membrane ion channel, the potassium
channel KcsA from Streptomyces lividans bacteria (Doyle et al., 1998). This crystal structure
allowed the determination of the molecular mechanism of potassium channel selectivity,
providing a glimpse of potassium ions trapped in the selectivity filter. The KcsA channel
monomeric unit is composed of two transmembrane helices (TM1 and TM2) linked together by a
pore helix, sharing homology with inward rectifier channels in these regions but of course
missing large chunks of the critical intracellular regions. The structure of intracellular regions of
similar channels would be solved independently, first by focusing on the Kir3.1 cytoplasmic
domain (Nishida and MacKinnon 2002), revealing the molecular underpinnings of inward
rectification and block by intracellular cations. Comparison of cytoplasmic domain structures
from Kir2.1 and Kir3.1 revealed a putative cytosolic gating element in the H-I loop, called the
“G-loop” gate because it forms a girdle around the central pore pathway (Pegan et al., 2005).
The first full-length structure of an inward rectifier came from a bacterial source, the
KirBac1.1 channel from Burkholderia pseudomallei (Kuo et al., 2003). KirBac1.1 is composed
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of a four-fold symmetric transmembrane domain similar to KcsA, and a cytoplasmic domain
consisting of beta sheets A thru M, resembling the isolated cytoplasmic domain structure
previously determined. At the base of the transmembrane TM2 helix, an inward facing
hydrophobic phenylalanine (F146) lines the pore, forming a barrier to potassium permeation. A
glycine residue (G143) approximately one helical turn above F146 presumably forms a hinge
point for the TM2 helix to bend, removing F146 block of the permeation pathway. This glycine
residue is absolutely conserved among Kir channels, and voltage-gated channels like Shaker and
Kv1.2 have a kink-inducing proline at the same position. A structural role for a different highly
conserved glycine, located at the halfway point of the TM2 helix, later challenged this
hypothesis, and has been implicated in the gating of several ion channels (Jiang et al., 2002),
including the G-mediated activation of Kir3 channels (Jin et al., 2002). Importantly, the
KirBac1.1 structure provided evidence for a new gating element, the slide helix, which is located
parallel to the plasma membrane and extends perpendicular to the trasmembrane domain helices,
reminiscent of the S4-S5 linker in voltage-gated potassium channels. While the structure
provides a wonderful first look at full-length inward rectifier channels, this prokaryotic channel
is functionally inhibited rather than activated by PIP2, as is the case with eukaryotic inward
rectifiers (Enkvetchakul et al., 2005). Therefore, the structural information on how PIP2
activates inward rectifier channels was necessarily limited in KirBac1.1.
A chimeric channel structure with a bacterial transmembrane domain (KirBac1.3) and a
eukaryotic cytoplasmic domain (Kir3.1) was solved in 2007, resulting in subunits with two
gating conformations, termed “constricted” and “dilated” based on whether the G-loop gate was
open or closed (Nishida et al., 2007). In the constricted form, sulfur atoms lining the G-loop
would prevent a hydrated potassium ion from permeating, whereas in the dilated form, the loop
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is wide enough, lined with oxygen atoms from T306 and G307. It is perhaps informative that the
crystals were grown in a short-chain analogue of PIP2, however the specific density of the PIP2
head group could not be placed in the structure. For the first full-length eukaryotic Kir channel
structure, MacKinnon’s group crystallized chicken Kir2.2. This structure has an open G-loop
gate and a closed inner helix bundle crossing gate (Tao et al., 2009). Importantly, chicken Kir2.2
would pave the way toward the first co-crystal of a channel with PIP2.
1.12. A Tale of Two Channels (and PIP2)
The co-crystal structure of chicken Kir2.2 and the short chain analogue DiC8-PIP2
presented for the first time a molecular picture of crystal contacts between the PIP 2 molecule and
a Kir channel. Scanning neutralization mutagenesis of positively charged residues to glutamine
made it clear that positive residues are involved in PIP2 activation and likely PIP2 binding itself,
but the exact channel-PIP2 binding interactions remained to be determined. In the co-crystal
structure, the head group of PIP2 makes elaborate contacts with positively charged domains of
Kir2.2 (Hansen et al., 2011). The 1’ phosphate of PIP2 sits in a nonspecific anionic phospholipid
binding site, interacting with backbone atoms of the RWR motif in the slide helix, positioning
the fatty acid tail between hydrophobic residues of the channel and the membrane bilayer. More
specific phosphatidylinositol binding is found between the 4’ and 5’ phosphates of PIP2 and
K183, R186, K188, and K189 of Kir2.2. The last amino acid of the KKR motif, R190, interacts
extensively with the cytoplasmic domain but does not form direct interactions with PIP 2. This
work also sheds significant light on a possible mechanism of PIP2-induced activation, whereby
PIP2 head group interaction with the cytoplasmic domain results in an upward translational
movement, connecting it to the transmembrane domain. Changes to the G-loop gate were
relatively minor, however.
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Around the same time, MacKinnon’s group crystallized the nearly full-length Kir3.2
channel (as opposed to the KirBac1.3/Kir3.1 chimeric channel) both in the presence and absence
of DiC8-PIP2 (Figure 1.6A) (Whorton and MacKinnon 2011). The PIP2-binding site is very
similar to the cognate site in Kir2.2, such that the 1’ phosphate interacts with the amide backbone
of the KWR motif, and the 4’ and 5’ phosphate interact with positively charged K194, K199, and
K200 (see Figure 1.6B). Details of the gating mechanism, however, are in stark contrast. Even
in the absence of PIP2, the cytoplasmic domain is juxtaposed to the transmembrane domain, so a
PIP2-induced upward translation (as in Kir2.2) is unlikely. The interface between the
transmembrane and cytosolic domain contains the C-D loop (or CD loop), a region containing
a residue implicated in sodium binding, Asp-228. When this residue is mutated to the neutral
asparagine, the channel no longer requires sodium for full activation (Ho and Murrell-Lagnado
1999; Zhang et al., 1999). Indeed, the crystal structure of the D228N mutant no longer has an
electron density for sodium ion at this position.
In both structures of the Kir3.2 channel, whether in the presence or absence of PIP2, the
cytosolic G-loop gate was closed, as was the helix bundle crossing gate. In order to obtain an
open G-loop gate structure, MacKinnon’s group systematically mutated several residues at the
interface between the transmembrane and cytosolic domains, then tested for activation using the
Gi-coupled GPCR M2. Using this methodology, they found that the mutation R201A had almost
no activation by the M2 receptor, yet its current was blocked by the Kir3 inhibitor Tertiapin-Q.
Interestingly, the R201Q neutralization mutant did not express detectable current.
The R201A mutant structure was crystallized in the presence and absence of PIP 2. The
G-loop gate that was closed in the wildtype channel was now in an open conformation, which
resulted from a rearrangement of the CD-loop. In the presence of PIP2, both the helix bundle
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crossing and G-loop gates were open. However, in the R201A mutant + PIP2 structure, only two
PIP2 molecules were bound per tetrameric channel. The authors state that this is likely a
crystallization artifact due to crystal packing, and thus in the normal state all four subunits would
have a bound PIP2 molecule. The R201A mutant is predicted to give a constitutively active
channel, insensitive to G-protein activation and thus in a fully active state. However, the channel
current is greatly diminished compared to the fully activated wildtype Kir3.2 current after M2
receptor activation with carbachol (Whorton and MacKinnon 2011). Thus the physiological
relevance of the R201A mutant conformation as “constitutively active” is still an open question.
1.13. PIP2-induced gating: Probable gating motions revealed from MD simulations
The co-crystal structures of Kir channels bound to PIP2 provide valuable insight as to the
channel binding pocket, and can differentiate direct interactions from allosteric when combined
with experimental data. There is limited information from snapshots of crystal structures of how
PIP2 binding induces gating, however. In the case of Kir3.2, for example, very little change is
evident from comparing absence and presence of PIP2, yet this channel clearly requires PIP2 for
activity. Meng et al. took a computational approach to examine PIP2-induced gating motions in
the chimeric Kir3.1 channel, by docking PIP2 to the constricted and dilated conformations (Meng
et al., 2012). These simulations implicated a role for the CD-loop in guiding the G-loop gate to
an open conformation. Tracking the trajectory from the constricted to the dilated state revealed
that the N-terminus forms a A interface with the M sheet of an adjacent subunit in the
presence of PIP2, whereas in the absence of PIP2 the N-terminus exists as a partially disordered
loop. Furthermore, the disordered N-terminal loop constrains CD-loop movement, which in turn
locks the G-loop gate in an inactive conformation.
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In the simulation, the constricted state with bound PIP2 adopted an intermediate
conformation resembling the dilated state. The interaction of PIP2 in the two conformations was
dynamic, such that some residues preferentially bound PIP2 in the constricted simulation, while
others bound only in the dilated simulation. In the constricted simulation, the PIP 2 binding
residues were K49 and R52 in the N-terminus, corresponding to K61 and K64 in Kir3.2, as well
as R190 in the C-linker helix, which corresponds to R201. In the dilated simulation, PIP2interacting residues were R66, K183, and R219, which correspond to R77, K194, and R230
respectively (Meng et al., 2012). Comparing with the co-crystal structure in Kir3.2, only K64 in
the N-terminus interacts with PIP2, but no interaction is seen for R201 or R230. This indicates
that the PIP2 binding site may be dynamic, proceeding through intermediate salt-bridge
interactions on the way to an optimized PIP2-binding conformation. Additionally, there may be
differences in the gating mechanisms and binding of PIP2 to Kir3.1 vs. Kir3.2, which has not
been explored in depth. In support of this, some differences in G activation between the two
channels are evident, where in purified protein systems (bilayers and vesicles, respectively) the
chimeric Kir3.1 and full-length Kir3.2 respond differently to G. Chimeric Kir3.1 is
functionally inhibited by G except in the presence of activated G (Leal-Pinto et al., 2010),
whereas Kir3.2 shows activation in the presence of G alone (Whorton and MacKinnon 2013).
1.14. Direct Activators of Kir3 Channels: G proteins and Ethanol
We will now close this chapter by focusing on known activators of Kir3 channels, and the
crystallographic or experimental evidence to date regarding the mechanism of activation.
Channels in the Kir3 family can be activated directly by G-protein G subunits, but also by
alcohols. Alcohol exerts a direct effect on channel activation independent of G-protein binding,
but the two mechanisms of activation may involve similar changes. A recent co-crystal structure
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of the Kir3.2 channel with G has been obtained, indicating that the channel binding interface is
composed of the L-M loop from one subunit and the D-E loop from an adjacent subunit
(Whorton and MacKinnon 2013). An independent computational study identified a similar G
binding cleft in Kir3.1* using protein-protein docking algorithms on the Kir3.1 chimera protein
structure and G. Experimentally, Kir3.1 channel activation was found to depend on the size of
the side chain at G(L55)keeping the L-M(L333) and D-E(F243) arms of the cleft apart
from one another. Alternatively, the cleft could be kept open electrostatically by the L55E
mutation on G acting on E334 and E335 of the L-M loop (Mahajan et al., 2013).
Synergy of PIP2 and G has been reported in Kir3 channels, such that binding of G
and subsequent activation seems to stabilize its interaction with PIP2. Channel inhibition by
PIP2-antibody is slowed in the presence of G, while reactivation by PIP2 is enhanced (Huang
et al., 1998; Zhang et al., 1999). Aside from G binding the channel with PIP2 in a ternary
complex, which is unlikely given the binding position discussed previously, it is instead more
likely that G binding and activation stabilizes the channel in a conformation that preferentially
binds PIP2. A similar allosteric mechanism may be at work in the I213L mutation of Kir2.3,
which increases apparent PIP2 binding affinity (Du et al., 2004; Zhang et al., 1999). Limited
structural evidence regarding exactly how a switch in hydrophobic residues (Ile to Leu)
influences PIP2 affinity exists, but a recent crystal structure of the Kir2.2_I223L mutant in the
presence and absence of PIP2 indicates that this mutation may force the G-loop gate into an
active, PIP2-bound conformation even in the absence of PIP2 (Hansen et al., 2011).
Interestingly, the putative alcohol binding pocket is located in approximately the same
position as the G binding site. Using a co-crystal structure of the cytosolic domain of Kir2.1
with the bound alcohol MPD (methylpentane-diol), Aryal and colleagues identified a putative
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alcohol-binding pocket with marked similarity to the G binding interface. It is composed of
the N-terminus and L-M loop from one subunit and the D-E loop from the adjacent subunit
(Aryal et al., 2009). The molecular pathway of conformational change in ethanol binding is
unclear, yet it seems likely that the mechanism is similar to G activation based on the location
of the binding site.
1.15. Sodium-dependent activation of Kir3 channels
The dependence on sodium to fully activate Kir3 channels is well-established, and
tremendous progress has been made to identify the sodium coordination site. Sodium-dependent
activation is thought to be a compensatory mechanism for increasing hyperpolarizing currents
during prolonged activity of excitable cells, which results in increased local sodium
concentration. A critical aspartate, Asp-228 in Kir3.2, has been shown to confer sodium
sensitivity in mutagenesis studies. Kir3.2, Kir3.3, and Kir3.4 all contain an aspartate at this
position, whereas Kir3.1 and most other Kir channels contain an asparagine, except Kir5.1,
Kir6.1, and Kir6.2. In the Kir3.2 crystal structure, sodium density is not present in the D228N
mutant. Neutralization of this aspartate experimentally increases whole-cell currents, and leads
to increased PIP2 apparent affinity, similar to effects of sodium in excised patches (Ho and
Murrell-Lagnado 1999). This has led to the hypothesis that sodium functionally neutralizes the
negatively charged aspartate, leading to an increase in net positive charge on the channel and
increased PIP2 binding (Rosenhouse-Dantsker et al., 2008). Alternatively, the negatively
charged aspartate shields an electropositive residue that directly binds to PIP2, such that sodium
binding would allow the positive residue to bind PIP2 unhindered.
Two studies have looked at structural mechanisms determining how sodium activates
Kir3 channels, with differing potential mechanisms. In Kir3.4, Rosenhouse-Dantsker et al.
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applied molecular dynamics simulations to the isolated cytoplasmic domain, modeled on Kir3.1,
to investigate how hydrogen-bond networks differ in the presence and absence of sodium. In the
absence of sodium, Arg-225 (equivalent to Arg-230 in Kir3.2) of Kir3.4 formed hydrogen bonds
with Asp-223 (Asp-228 in Kir3.2), with both residues located in the CD loop. The presence of
sodium frees Arg-225 from hydrogen bonding with Asp-223, which presumably allows it to
interact with PIP2. Furthermore, a downstream histidine residue which corresponds to His-233
in Kir3.2, is involved in conferring sodium sensitivity. Kir6.2 is not sodium sensitive, likely due
to a methionine instead of a histidine at the equivalent position (Rosenhouse-Dantsker et al.,
2008).
The corresponding residue to Arg-230 in Kir2.1, Arg-218, greatly reduces current levels
when mutated to the neutral glutamine, and increases the kinetics of PIP2-antibody inhibition, a
marker of reduced channel-PIP2 interaction. Importantly, tagging an R218C mutant with the
positively charged sulfhydryl modifying reagent MTSEA both increases channel currents and
slows the kinetics of PIP2-antibody inhibition (Lopes et al., 2002). These results imply that
R218C is accessible to intracellular modification, and that incorporation of positive charge can
restore channel-PIP2 interactions.
Crystallographic studies of the isolated Kir3.2 cytoplasmic domain both in the presence
and absence of sodium implicate the N-terminal His-69 residue in the sodium coordination site.
The mutant H69Q has a greater response to applied PIP2 than the wildtype channel, but still
responds to sodium. The mutant D228N does not retain sodium sensitivity, and has higher PIP 2
response as well. The authors contend that sodium-mediated gating may involve an interaction
between the CD loop and the N-terminus, which is stabilized by the presence of sodium (Inanobe
et al., 2010). The exact mechanism for how sodium increases channel activity remains
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unresolved, although different mechanisms toward the same goal of activation may be at work in
Kir3.2 and Kir3.4.
1.16. Conclusion
In the case of Kir3 channels, activators like PKA phosphorylation, G, or sodium, seem
to converge on promoting channel-PIP2 interactions. Similarly, accumulating evidence indicates
that inhibitory PKC phosphorylation likely acts by reducing channel-PIP2 interactions. We can
think of the channel as existing in an equilibrium between at least two energy minima or
conformations, representing either an inactive or active state. The channel gates (selectivity
filter, helix bundle crossing, and G-loop) all need to be in the open conformation for the active
state. The active state is promoted by PIP2 binding, whereas conversely the inactive state
becomes less energetically favorable in the presence of PIP2. Activators like PKA
phosphorylation, G, or sodium (and possibly ethanol) would then stabilize the active state,
which could occur along the same pathway as PIP2 stabilization or independently. Inhibition,
like that mediated by PKC phosphorylation, would shift the equilibrium to the inactive state,
making the active state less energetically favorable, resulting in reduced channel-PIP2
interactions. In the case of Kir3.2, a fully active conformation is proposed in the context of the
R201A mutant (Whorton and MacKinnon 2013), but it is unclear if this is a physiologically
relevant conformation. Presumably PKC phosphorylation acts to inhibit Kir3.2 by stabilizing an
inactive conformation, making the active conformation less energetically favorable. We explore
this idea in detail using putative phosphorylation site-specific mutants and analyzing their impact
on PKC inhibition and gating in the next chapters.
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Hypothesis
For Kir channels and GIRK channels in particular, phosphorylation presents a reversible,
fast means to modulate channel activity. Phosphorylation likely involves pathways of activation
or inhibition inherent to channel function, with PIP2 a likely candidate due to its central role. We
hypothesize that phosphorylation by PKC manifests its functional effect by reducing channelPIP2 interactions, and set out to investigate this hypothesis using a combined experimental and
computational approach.
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Table 1.1. PKC sensitivity of Kir Channels.
Channel
[Alias]

Functional Effect of PKC

Target
residues

In vitro PKC
phosphorylation?

System

Kir1.1
[ROMK1]
Kir2.1
[IRK1]
Kir2.2
[IRK2]
Kir2.3
[IRK3]
Kir3.1
[GIRK1]

Shifts pKa;
Inhibits
None

T193

Yes, multiple

none

Not tested

Xenopus;
CCD(ISK)
Xenopus

Inhibits

none

Not tested

Xenopus

Inhibits

T53

Not tested

Xenopus

Inhibits

S185

Yes, not sitespecific

Kir3.2
[GIRK2]

Inhibits

None

None

Kir3.4
[GIRK4]

Inhibits

S191

None

Kir4.1/5.1

Inhibits

None

Kir6.1
[KATP]

Inhibits

Kir6.2
[KATP]

Activates;
Stimulates channel
internalization;
Inhibits

S354,
S379,
S385,
S391,
S397
T180;
S372

Yes, not sitespecific
Yes, multiple

Xenopus,
COS-7,
atrial
myocytes
(IK,Ach)
Xenopus,
Hippocampal
neurons
(GABAB),
HEK293
Xenopus,
atrial
myocytes
(IK,ACh)
Xenopus,
HEK293
HEK293

Kir7.1

Inhibits

S201
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Yes

HEK293;
Xenopus

Not tested

Xenopus

Figure 1.1. Kir channel phylogeny and topology. A. Phylogenetic tree of Kir channels. B.
General topology of a Kir channel, as compared to a Kv channel. Adapted from Hibino et al.,
2010.
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Figure 1.2. Channelopathies of Kir Channels. Schematic of Kir channels with tissuespecific expression and recognized channelopathies. Up arrows indicate gain of function,
while down arrows indicate loss of function mutations. Modified from Pattnaik et al., 2012.
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Figure 1.3. Schematic of phosphoinositide interconversion and PIP2 hydrolysis. The
phosphatidylinositol (PtdIns) precursor can be interconverted into seven different
phosphorylated species by phosphatidylinositol kinases and phosphatases. Wortmannin
inhibits PI3K and PI4K at high micromolar concentrations. PLC hydrolysis of PIP 2 results in
DAG and IP3. DAG activates PKC directly, but increases in calcium via IP3 action also
activate calcium-sensitive PKCs.
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Figure 1.4. Alignment of selected eukaryotic Kir channels. PIP2-binding residues
determined experimentally are colored in blue. Potential phosphorylation sites are boxed and
colored in green. Structural domains are highlighted by a gray background. HBC: helix
bundle crossing; SF: selectivity filter. Relevant PIP2 sites in Kir3.2 are: K64, R77, K90,
W91, R92, K194, K199, K200, R201, R230, R240, and R324. R201, R230, R240 and R324
do not bind PIP2 in the crystal structure. Relevant phosphorylation sites are: S196 (PKC in
Kir3.1/3.4), T204 (PKA in Kir3.1/3.4, PKC in Kir6.2), S232 (PKA in Kir1.1), S326 (PKA in
Kir1.1). Channel numbering is according to the human isoform, except for Kir3.2, which is
mouse.
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Figure 1.5. Neuronal excitation by Substance P results from inhibition of an inwardly
rectifying potassium current. Substance P application to globus pallidus neurons results in
a depolarization attributed to a reduction in inward potassium current. A. In current-clamp
mode, Substance P evokes a reversible depolarization. B. In voltage-clamp mode, Substance
P application results in a temporary reduction of inward rectifying currents. C. SP-sensitive
current is inward rectifying and reversal potential shifts according to EK. D. SP-sensitive
conductance is half-maximal at EK. Adopted from Stanfield et al., Nature 1985.
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Figure 1.6. Kir3.2 structure and location of PIP2-binding residues. A. Tetrameric Kir3.2
channel with differential coloring of monomers. B. Close-up of PIP2 binding site. C-linker
contains the K199 and K200 in the KKR motif. Adapted from Whorton et al., 2011.
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Chapter 2. MATERIALS AND METHODS

2.1.

Molecular Biology
For expression in Xenopus oocytes, the following vectors were used: pGEMHE (for

Kir3.1 and Kir3.4), pXoom (for Kir3.2), and pSD64TF (for Ci-VSP). Point mutations were
introduced using standard Pfu-based mutagenesis technique according to the QuikChange
protocol (Stratagene) and mutations were verified by sequencing (Genewiz). Plasmids were
linearized prior to in vitro transcription using a commercially available T7 mRNA transcription
kit, with the exception of pSD64TF, which used SP6 mRNA transcription kit.
2.2.

Reagents
Wortmannin, PMA, Mg-ATP and Bis-indolylmaleimide II (Bis) were purchased from

Sigma. DiC8-PIP2 was purchased from Avanti. Alkaline phosphatase (Calf intestinal
phosphatase or CIP) was from New England Biolabs.
2.3.

Oocyte preparation and injection
Oocytes from Xenopus laevis were surgically removed and subjected to collagenase

treatment according to standard protocols. Once defolliculated, oocytes were transferred to OR2
solution supplemented with Ca2+ and Penicillin/Streptomycin antibiotics. Stage V or VI oocytes
were injected with 50 nL of cRNA resuspended in DEPC water. For wortmannin treatments,
oocytes were incubated in wortmannin-containing OR2 at 50 uM final concentration for two
hours prior to experiments. For Bis treatment, 30 nL of 150 uM Bis (diluted in ND96K) was

42

injected into oocytes two hours prior to experiments. Oocytes were also incubated in 5 uM Bis
(in OR2 media).
2.4.

Two Electrode Voltage Clamp
Borosilicate glass electrodes were pulled using a Flaming-Brown micropipette puller and

filled with a 3M KCl solution containing 1.5% agarose. Resistances were kept between 0.3 and
1.0 MCurrents were recorded 1-3 days after injection using a GeneClamp 500 amplifier
(Axon Laboratories). A voltage ramp protocol was used to monitor inward current, from -80 mV
to +80 mV at a holding of 0 mV. Specialized Ci-VSP protocols were used to monitor impact of
PIP2 depletion on channel current. To obtain the percentage of PMA inhibition, the PMAinhibited current at -80 mV (Imax - Ipost-PMA) was divided by the maximal current at -80 mV (Imax)
prior to PMA application. In channels with very small currents (less than 1 uA, as in Kir3.2WT
or Kir3.2_I234L_196Q), the raw current was first barium-subtracted to exclude endogenous
inward currents from the analysis, which were typically 200 to 300 nA at -80 mV. Barium
subtraction was then applied to all members of the test group. The ND96K (HK) solution used
to monitor inward current contained (in mM): 96 KCl, 10 HEPES-K, 1 MgCl2, 1.8 CaCl2, pH
7.4. ND96 (LK) contained: 96 NaCl, 2 KCl, 5 HEPES-Na, 1 MgCl2, 1.8 CaCl2, pH 7.4. PMA
was dissolved in DMSO to make a 10 mM stock, and diluted into ND96K for a 300 nM final
concentration. For barium block, a solution of 5 mM BaCl2 in ND96K was perfused.
2.5.

Inside-out Macropatch
The vitelline membrane was manually peeled using forceps to gain access to the oocyte

plasma membrane. Pipettes were pulled using a Flaming-Brown micropipette puller and then
fire-polished to give a final resistance of 0.5 to 2 MCurrents were acquired at 10 kHz and
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filtered at 2 kHz using pClamp software and the Axopatch 200A amplifier (Axon Instruments).
Inward currents were monitored using a ramp protocol from -80 mV to +80 mV, with holding
potential at 0 mV. Following gigaseal formation, the pipette was pulled away from the
membrane to achieve the inside-out patch, and perfused directly using a multi-barrel gravitydriven perfusion apparatus. Pipette solution (in mM): 96 KCl, 10 HEPES, 1.8 CaCl2, 1 MgCl2, 1
NaCl, pH 7.4. Bath solution (in mM): 76 KCl, 20 NaCl, 5 EGTA, 10 HEPES, pH 7.4. For
MgATP solution, 100 mM MgATP in dH2O was added to the bath solution for a final
concentration of 2 mM, then the pH was adjusted to 7.4. For AP experiments, 100 U/mL AP
was made in the bath solution with 10 mM MgCl2. DiC8-PIP2 was added to this same solution
without AP.
2.6.

Molecular Dynamics
For simulations, systems were set up similar to Meng et al., 2012. Briefly, a channel

tetramer was generated from the crystal coordinates of PDB code 3SYA, corresponding to Kir3.2
with DiC8-PIP2 and sodium. The acyl chains of native PIP2 (20:4, Arachidonyl-stearyl) were
manually built with Discovery Studio onto the crystal PIP2 headgroup. The tetramer was
inserted into a POPC membrane via the INFLATE script. The system was solvated (SPC model)
and ionized (0.15 KCl) in GROMACS, then sodium ions and potassium ions were manually
added to the sodium site and the selectivity filter, respectively, by superimposition using the
3SYA structure. The 53a6 GROMOS forcefield was altered to include parameters for PIP 2 and
phosphoserine (SEP). After minimization using a steepest descent algorithm, two equilibration
runs were executed with progressively weaker position restraint (1000 then 10) on heavy atoms,
followed by a 100 ns production run with no restraints. Simulation analysis was run using
GROMACS, Simulaid, and VMD programs.
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2.7.

Protein Expression and Purification

Mouse Kir3.2NC cytoplasmic domain was cloned into a modified pET-28b vector (the
prokaryotic pSMT3 small ubiquitin-related modifier (Sumo)/His-tag fusion system). The HisSUMO fusion protein was expressed in E. coli strain Rosetta2(DE3) (Novagen). The sequence
of the Kir3.2 cytoplasmic domain (excluding the His-SUMO tag) used for expression is as
follows (with the linked N-terminus underlined):
RKIQRYVRKDGKCNVHHGNVREKRAETLVFSTHAVISMRDGKLCLMFRVGDLRNSHIV
RASIRAKLIKSKQTSEGEFIPLNQTDINVGYYTGDDRLFLVSPLIISHEINQQSPFWEISKAQ
LPKEELEIVVILEGMVEATGMTCQARSSYITSEILWGYRFTPVLTLEDGFYEVDYNSFHE
TYETSTPSLSAKELAELANRAEL
This N-terminal His-SUMO tag fusion protein fragment was expressed, solubilized, and
purified on a nickel column as previously described (Zhang et al., 2012). Briefly, Kir3.2NC
protein was expressed in IPTG auto-induction media and shaken overnight at 30 °C. The
bacterial pellet was resuspended in lysis buffer containing a protease inhibitor cocktail and
sonicated to release soluble protein, then centrifuged and the pellet was discarded. The
supernatant was loaded onto a pre-equilibrated Ni-NTA column, and the bead-lysate mixture was
gently resuspended for one hour at 4 degrees C. The beads with bound protein were loaded back
onto the column, which was then washed with 20 mM imidazole-containing lysis buffer for 10
column volumes. Protein was eluted with 500 mM imidazole. To cleave the His-SUMO tag,
ubiquitin-like protease 1 (Ulp1) was added to the protein sample and dialyzed in 150 mM KCl,
20 mM Tris, pH 8.5; 10% sucrose, and 1 mM TCEP overnight at 4 °C. After digestion, proteins
were subjected to a second affinity chromatography step to remove the cleaved His-SUMO
fragment. The flow-through was collected and concentrated to ~1 mL using Amicon Ultra
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conical spin tubes. An SDS-PAGE gel was run to assess purity, and concentration was
quantified (0.3 mg/mL) using the OD280 with calculated extinction coefficient.
2.8.

In Vitro PKC Phosphorylation
PKC phosphorylation was carried out according to the manufacturer’s instructions

(Promega). Briefly, a 4X PKC buffer was prepared containing (in mM): 80 HEPES, 6.8 CaCl2,
40 MgCl2, 4 DTT, 0.6 Na-ATP, pH 7.4. Phosphatidyl-serine (PS) was dried under nitrogen gas,
then PKC buffer was added to the dried lipid and sonicated in a bath sonicator to achieve a final
PS concentration of 2.4 mg/mL. For the PKC reaction, 30 ug of purified Kir3.2NC in 1X PKC
buffer was incubated with 1 uL (25 ng) of PKC and 300 nM PMA for 1.5 hours at 30 degrees C.
Reaction was terminated by adding 4X SDS sample buffer. Samples were boiled and loaded
onto an SDS-PAGE gel. The gel was stained with Pro-Q Diamond Phosphoprotein Gel Stain
(Invitrogen) according to the manufacturer’s instructions. Briefly, the gel was fixed overnight
with 50% methanol, 10% acetic acid solution, washed 4 x 15 min with MilliQ water, and stained
for 2 hours with ProQ PhosphoStain. The staining step and all steps thereafter were performed
in the dark. The gel was destained 4 x 30 min with a solution containing 50 mM Na-Acetate (pH
4.0) and 20% acetonitrile. Then the gel was washed 2 x 10 min with MilliQ water prior to
visualization on a Typhoon fluorescent image scanner set to excitation at 532 nm and emission at
560 nm.
2.9.

Statistics
All error bars represent the standard error of the mean (SEM). Statistical significance

was assessed using Student’s t-test assuming unequal variance between samples in Origin 8.5
(OriginLab). Statistical significance was set at p < 0.05, denoted by an asterisk * in figures. For
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Ci-VSP mediated current inhibition, a single-component exponential function was fit to the
descending phase of the data and the tau was extracted. For normalized current data, bariumsubtracted currents for each group were divided by the mean of the control group. All
experiments were repeated in at least two separate batches of oocytes.
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Chapter 3. PHOSPHORYLATION AT SERINE 196 REGULATES GATING OF KIR3.2
CHANNELS AND ALLOSTERICALLY COUPLES TO PKC INHIBITION

3.1.

Introduction
Mutagenesis studies by Mao et al. in Kir3.1 and Kir3.4 identified a critical serine residue

(S185 in Kir3.1 and S191 in Kir3.4) implicated in PKC-mediated phosphorylation. When the
corresponding serine was mutated to alanine or aspartate, PMA inhibition was significantly
reduced. Additionally, inhibition in excised patches by purified PKC was no longer effective.
These results led the authors to conclude that Ser-185/Ser-191 was the major PKC
phosphorylation site in Kir3.1/3.4 heterotetrameric channels (Mao et al., 2004).
We sought to identify a structural mechanism for how phosphorylation might affect
gating by using a structure-function approach in the Kir3.2 channel, for which the full-length
crystal structure is available with and without PIP2 (Whorton and MacKinnon 2011). The PKC
site identified in Kir3.1 and Kir3.4 corresponds to Ser-196 in Kir3.2, and is located at the base of
the TM2 helix (see Figure 3.1A). The side chain of Ser-196 lines the permeation pathway,
located one helical turn below the helix bundle crossing residue F192. The G-loop gate, another
cytosolic gating element, is located directly below Ser-196. In addition, residues forming saltbridge interactions with PIP2 are nearby (Figure 3.1B), including K194 (upstream), K199, and
K200 (both downstream). All of these elements make Ser-196 a prime target for gating
modification by phosphorylation.
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Given the exciting position of this residue, we sought to test the PKC inhibition of Kir3.2
at the analogous position to Kir3.1/Kir3.4 S185/S191. Our experiments utilized channels
expressed in Xenopus oocytes, followed by PMA perfusion and quantification of the resulting
inhibition. We also employed molecular dynamics simulations with in silico channel mutants to
identify protein-protein network interaction changes mediated by mutation of specific residues.
3.2.

Results

3.2.1. PMA inhibition of homomeric GIRK channels
We first examined the homomeric channel mutants in the Kir3.x family, using previously
described mutations that enhance homomeric activity, known as Kir3.1* (F137S) (Chan et al.,
1996), Kir3.4* (S143T) (Vivaudou et al., 1997), and Kir3.2* (E152D) (Yi et al., 2001). We
perfused 300 nM PMA, a membrane-permeable PKC activator, and quantified the extent of
inhibition for Kir3 homomeric channels. To determine the extent of inhibition, the PMAsensitive current (Imax-Ipost-PMA) was divided by the current prior to PMA application (Imax), and
expressed as a percentage (see Figure 3.2A, left panel). Consistent with the results in Mao et al.,
Kir3.4*_S191A and Kir3.1*_S185A both had significantly reduced PMA inhibition compared
with their respective channels (Kir3.1*S185A 46.8 +/- 0.8 % vs. Kir3.1* control 80 +/- 1.4%,
Figure 3.2B; Kir3.4*S191A 57 +/- 2.1% vs. Kir3.4* control 88.3 +/- 0.7%, Figure 3.2A). The
phosphomimetic Kir3.4* S191D exhibited 10 +/- 5.6% inhibition, resulting in a significant
reduction compared to Kir3.4* S191A, as reported by Mao et al. (Figure 3.2A). We also tested
the Kir3.1*_S185D mutant, which displayed 67.6 +/- 8.4% PMA inhibition, and was not
statistically significant from Kir3.1* control (Figure 3.2B), in contrast to Kir3.1*_S185A. This
mutant was not tested in Mao et al. for PMA inhibition.
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In the Kir3.2* channel, PMA inhibition of the phosphomimetic S196E mutant was not
significantly different from Kir3.2* control (Kir3.2* 27 +/- 5.4% vs. Kir3.2*_S196E 19.5 +/- 5.2
%, Figure 3.2C). Surprisingly, the Kir3.2*_S196Q neutralization mutant had significantly
higher PMA inhibition (53.8 +/- 4.2%) than either Kir3.2* control or S196E. These results
indicate that Kir3.2* has increased PMA inhibition after neutralization of Ser-196, compared to
Kir3.1* or Kir3.4*, which have the opposite effect, reduced PMA inhibition.
We then compared the current levels by normalizing to the homomeric control channel.
Both Kir3.1*_S185A (4.0% of control) and Kir3.1*_S185D (2.6% of control) resulted in
significant reductions in current level compared to Kir3.1* control (Figure 3.3B). Currents of
the mutants were essentially undetectable, requiring longer expression times than Kir3.1* for
detectable current (as in Figure 3.2B). Kir3.4*_S191A (98 +/- 16.7%) had similar current levels
to Kir3.4* control, while Kir3.4*_S191D had significantly diminished currents (11.5 +/- 0.3%)
(Figure 3.3A). In the Kir3.2* channel, the S196Q mutant was 20 +/- 1.8% of control, while the
Kir3.2*_S196E mutant was closer to Kir3.2*, at 69.0 +/- 3% (Figure 3.3C). These results
indicate that residue substitution at this position in different Kir3 channels is heterogeneous.
Kir3.4* follows a pattern consistent with the phosphomimetic residue playing a role in PMA
inhibition, namely that the S191D mutant has significantly reduced currents, while S191A does
not change current level. Kir3.1*, on the other hand, has significant current reduction after
substitution by either Ala or Asp. For Kir3.2*, the neutralization mutant S196Q significantly
reduces currents, while phosphomimetic S196E has currents that are closer to control.
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3.2.2. MD Simulations predict a switch mechanism dependent on phosphorylation of Ser196
We hypothesized that the channel may be constitutively phosphorylated at position Ser196, and that neutralization or dephosphorylation will affect gating behavior. To further
examine how phosphorylation at this residue affects gating, we ran molecular dynamics
simulations using the crystal structure of the Kir3.2 channel with bound PIP2 (PDB code 3SYA),
and performed mutations at Ser-196 in silico using a background mutation of E152D as with our
experimental results. We first analyzed protein salt-bridge interactions, comparing S196Q and
S196E mutants. In the S196Q mutant, a strong salt-bridge interaction persists between Asp-228
and Arg-201 of each subunit. Over the course of the simulation in S196E, the negatively
charged Glu-196 recruits Arg-201 away from Asp-228. The carbon-to-carbon distance averaged
over the four channel subunits is depicted in Figure 3.4 for both S196Q and S196E. Consistent
with the salt-bridge results for S196E, the average distance for Arg-201/Asp-228 increases (from
~ 4 Å to ~8.1 Å, while simultaneously the distance for Arg-201/Glu-196 decreases (from ~10 Å
to ~6.5 Å), allowing interaction. In the S196Q mutant, the average distance for Arg-201/Asp228 and Arg-201/Gln-196 does not change appreciably over the 100 ns simulation, and
furthermore does not show the same coordination as S196E (compare Figure 3.4A with Figure
3.4B).
Inspection of the trajectories as well as an 80 ns snapshot of the two simulations (Figure
3.4C-D) indicates that in S196E, Arg-201 moves away from Asp-228 and swings upward to
form interactions with Glu-196. In S196Q, Arg-201 firmly interacts with Asp-228 for the
duration of the simulation.
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Given that S196Q has a neutral charge and S196E would have a strongly negative charge,
we performed the same simulations on a channel with either Ser-196 (E152D control) or
Phosphoserine-196. The pattern of salt-bridge interactions was consistent with our previous
results for the S196Q and S196E mutants. Only the phosphorylated serine (SEP) forms saltbridge interactions with Arg-201, recruiting the residue away from Asp-228 as shown in the
average distance plots and an 80 ns snapshot (Figure 3.5).
As mentioned earlier, the Ser-196 residue is located approximately one helical turn from
a key gating residue Phe-192, which forms the helix bundle crossing gate. We examined the
intersubunit distance of this gate by calculating the minimal distance of residue-residue
interactions. Interestingly, the S196E mutant adopts a half-open conformation at the helix
bundle crossing, whereby the intersubunit A-B distance increases, but the intersubunit C-D
distance does not (Figure 3.6B). In the S196Q mutant both intersubunit F192 distances remain
stable, and the gates maintain a closed conformation (Figure 3.6A).
3.2.3. Mutation of Arg-201 affects gating and PMA inhibition
The outcome of the simulations suggested a switch mechanism whereby phosphorylation
at Ser-196 can recruit Arg-201 away from Asp-228. The mutant Kir3.2_R201A has been
crystallized, demonstrating a putative open G-loop structure, as well as a half-open helix bundle
crossing gate in the presence of PIP2. It has been suggested to adopt a fully active state
resembling Gbinding (Whorton and MacKinnon 2011; Whorton and MacKinnon 2013). We
found that in the Kir3.2* background, the R201A mutant produces very small currents, nearly
indistinguishable from background (Figure 3.7B). An additional mutation D228N (Kir3.2*_
D228N_R201A) potentiates the current more than 20-fold, but the currents are still significantly
reduced compared to either D228N alone or Kir3.2*. On its own, the mutant Kir3.2*_D228N
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potentiates Kir3.2* currents approximately twofold (Figure 3.7A). This result suggests that
mutation of R201 is detrimental to channel activity, and that the negatively charged Asp-228
greatly reduces channel activity.
Given that the S196Q mutant has increased PMA inhibition as well as diminished
currents, we tested the PMA inhibition of the Kir3.2*_D228N_R201A mutant, finding that it was
significantly increased compared to Kir3.2*_D228N alone (47.5 +/- 3.6% for
Kir3.2*_D228N_R201A vs. 19 +/- 3.9% for Kir3.2*_D228N, Figure 3.7C). These results
indicate that the putative interaction of Arg-201 with phosphorylated Ser-196 is important for
both channel activity and PKC inhibition.
3.2.4. Global changes in phosphorylation affect PIP2-induced gating
We proceeded to functionally test the channel for phosphorylation at Ser-196 by
perfusing the channel with a nonspecific phosphatase in an excised inside-out macropatch.
When the patch is excised, PIP2 levels rapidly decrease due to endogenous lipid phosphatase
activity, manifesting as channel rundown. We used Mg-ATP to reactivate the channel and then
perfused calf intestinal phosphatase (CIP, 100 U/mL) reconstituted in the Mg-ATP solution.
Perfusion of the phosphatase led to rapid channel inhibition, which recovered upon washout
(Figure 3.8A). Recovery of the current by Mg-ATP is thought to be dependent on PIP5K
activity, so it is possible that the phosphatase can nonspecifically decrease PIP2 levels, perhaps
by dephosphorylating PIP5K. We tested more directly how channel dephosphorylation affects
PIP2-induced gating by perfusing DiC8-PIP2. Perfusion of DiC8-PIP2 after CIP treatment
resulted in greater current recovery compared to diC8-PIP2 alone. This was more pronounced
with 5 M PIP2 than 50 M PIP2, suggesting that CIP treatment changes channel affinity for
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PIP2. These results imply that nonspecific dephosphorylation of Kir3.2 results in greater PIP 2
activation, possibly by changing PIP2 affinity, although this was not explicitly tested.
3.3.

Discussion
Our study thus far has identified a residue interaction triangle in the Kir3.2 channel,

where the key players are Ser-196, Arg-201, and Asp-228. Phosphorylation of Ser-196 presents
a toggle switch, which recruits Arg-201 away from Asp-228. This in turn results in increased
channel activation and lower sensitivity to PMA inhibition. Disruption of the SEP-196/Arg-201
interaction, either by S196Q or R201A, results in a channel with greatly reduced currents, as well
as higher sensitivity to PMA inhibition.
The mutagenesis and simulation data imply that phosphorylation can change both gating
and PKC inhibition, yet biochemical identification of phosphorylation at Ser-196 remains to be
determined. This work further implies that changes at allosteric sites can affect functional
inhibition by PKC, casting doubt on the work of Mao et al. in identifying the functional site of
phosphorylation in Kir3.1/3.4 channels. Although it is still possible that the sites in Kir3.1/3.4
(S185/S191) and Kir3.2 (S196) are different, the mutagenesis data on homomeric channels
seems to suggest otherwise. While alanine mutants Kir3.1*_S185A and Kir3.4*_S191A have
less overall inhibition than their wildtype counterparts, the aspartate mutants differ.
Kir3.1*S185D has higher inhibition, similar to Kir3.1* control, but Kir3.4*S191D has even
lower inhibition than G4*S191A. These data suggest that in terms of PMA inhibition, at least
one other phosphorylation site is involved besides Kir3.1_S185/Kir3.4_S191. One caveat in
these studies regards the low current levels of the Kir3.1*_S185 mutants, such that much longer
expression times were required. This resulted in greater variability of PMA inhibition than
compared to Kir3.4*, for example. The conclusions of Mao et al. in regard to Kir3.4*
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phosphorylation at Ser-196 are therefore still applicable, but with the specific case of Kir3.1*
Ser-185, the data are inconclusive. Our mutagenesis data strongly suggest that Ser-196 is not
directly phosphorylated in the context of PMA inhibition, but rather acts as an allosteric
regulator.
The mutagenesis results in Kir3.2* suggest a dependence of PKC-mediated inhibition on
phosphorylation at an allosteric site, Ser-196 (see Figure 3.9). When Ser-196 is phosphorylated,
the helix bundle crossing gate is stabilized and the channel is less sensitive to PKC inhibition.
Phosphorylated Ser-196 competes with Asp-228 for the critical Arg-201. In the absence of
phosphorylation, Asp-228 tightly interacts with Arg-201, stabilizing the closed state.
Interestingly, the R201A mutant has been used to obtain the crystal structure of Kir3.2 with an
open G-loop gate. In the presence of PIP2, this mutant is thought to have a partially open helix
bundle crossing gate as well. Presumably due to packing of crystal contacts, only two PIP2
molecules are bound per tetramer, such that one monomer has an open helix bundle crossing and
its partner maintains a PIP2-deficient structure. Therefore, the R201A mutant has been described
as a constitutive, fully active channel (Whorton and MacKinnon 2011). However, the current
levels of Kir3.2*_R201A are drastically reduced compared to the Kir3.2* control.
Neutralization of Asp-228 with the D228N mutant rescues Kir3.2*_R201A currents more than
twenty-fold, much greater than the effect of D228N alone on Kir3.2* (approximately two-fold).
The Kir3.2*_D228N_R201A double mutant has increased sensitivity to PKC inhibition
compared to the Kir3.2*_D228N control.
The potentiation effect of the D228N mutation on Kir3.2*_R201A indicates that Asp-228
likely inhibits the channel in the absence of the Arg-201 side-chain. Asp-228 is a critical residue
for sodium potentiation, whereby sodium binding shields the negatively charged aspartate from
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positive PIP2-interacting residues (Ho and Murrell-Lagnado 1999; Inanobe et al., 2010; Whorton
and MacKinnon 2011). A likely candidate for interaction is Arg-230, located two residues away
on the CD-loop. Simulations in a homology model of Kir3.4 indicate that sodium coordination
prevents interaction between Asp-223 and Arg-225 in Kir3.4, the homologous residues to Asp228 and Arg-230 (Rosenhouse-Dantsker et al., 2008). In the co-crystal of Kir3.2 and PIP2, Arg230 does not form interactions with PIP2, but it is possible that Arg-230 interacts with Asp-228
in some intermediate PIP2-binding state. Evidence from MD simulations in the Kir3.1-chimera
structure points to this possibility, where the equivalent residue (Arg-230 equivalent) makes PIP2
contacts in the dilated conformation intermediate state only (Meng et al., 2012).
The mutagenesis data regarding current levels and PMA inhibition strongly suggest that
Ser-196 is normally phosphorylated in Kir3.2 expressed in Xenopus oocytes. This has not been
tested explicitly, however. A phospho-antibody for Ser-196 does not exist, but there are indirect
methods to identify phosphorylation at this site. For example, immunoprecipitates of Kir3.2*
and Kir3.2*_S196Q or S196E could be compared, and there should be a reduction in
incorporated 32P in the mutants when compared to control.
In the absence of phosphorylation at Ser-196, it seems unlikely that Ser-196 (an
uncharged, polar residue) would function equivalently to Glu-196 (a negatively charged residue).
Since the principal difference between Gln and Glu is the introduction of negative charge, we
believe that Ser-196 is likely in a phosphorylated state. It remains to be determined whether
Kir3.1 and/or Kir3.4 also might be constitutively phosphorylated at this position, confounding
the mutagenesis results on PKC inhibition in Mao et al.
Finally, experiments in the excised inside-out patch configuration indicate that Kir3.2*
channels respond differently to PIP2 after global dephosphorylation by nonspecific phosphatase
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treatment. Importantly, different phosphorylation signals likely converge to determine channelPIP2 affinity. In the Kir1.1 channel, PKA phosphorylation increases channel-PIP2 affinity and
results in higher channel activity (Liou et al., 1999). PKA phosphorylation in Kir3.1/3.4
channels also can activate channels, likely by increasing channel-PIP2 affinity (Lopes et al.,
2007). In the case of Kir3.2* channels, the balance of phosphorylation before CIP treatment is
inhibitory, as dephosphorylation results in larger PIP2-induced currents. Testing specific
phosphorylation site mutants with this paradigm will be instrumental in determining how
phosphorylation at specific sites contributes to channel-PIP2 interactions. Interestingly, an
examination of IK,Ach currents and heterologously expressed Kir3.1/3.4 channels demonstrated
that G-dependent activation was abolished after treatment with PP1 phosphatase. The
phosphorylation site(s) could not be pinpointed, but the phosphatase effect was dependent on the
distal C-terminus of Kir3.1 channels (Medina et al., 2000). This also indicates that changes in
global phosphorylation can affect channel activation, this time by the activator G.
In summary, we have identified a likely constitutively phosphorylated site in the Kir3.2
channel at Ser-196. Phosphorylation of this residue leads to increased gating and reduced
sensitivity to PMA inhibition in homomeric Kir3.2*. MD simulations suggest that
phosphorylated Ser-196 interacts with Arg-201, pulling Arg-201 away from Asp-228.
Neutralization of either Ser-196 or Arg-201 results in diminished activity and increased
sensitivity to PMA inhibition. Surprisingly, nonspecific phosphatase treatment of Kir3.2*
resulted in increased PIP2 activation, suggesting that the global phosphorylation signal output is
inhibitory.
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Figure 3.1. Ser-196, a putative PKC phosphorylation site, is located in a key position to
affect gating behavior. A. Location of Ser-196 in relation to the F192 helix bundle crossing
gate and the G-loop gate. B. Slight rotation along Y-axis depicting nearby PIP2-binding
residues: K194, K199, and K200. K64 from N-terminus is also depicted.
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Figure 3.2. PMA Inhibition of Kir3.4*(S143T), Kir3.1*(F137S), and Kir3.2*(E152D)
and serine mutants. A. Left, time course of PMA inhibition for Kir3.4* and S191D with
time points measured indicated by arrows. Right, summary PMA inhibition data for Kir3.4*
and S191 mutants. **, S191D has a statistically significant difference from S191A at p<0.05.
B. Left, time course for Kir3.1* and S185D. Right, summary data for Kir3.1* and S185
mutants. C. Left, time course for Kir3.2* and S196Q. Right, summary data for Kir3.2* and
S196 mutants. *, p <0.05 compared to control.
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Figure 3.3. Normalized currents for neutralization and phosphomimetic serine mutants.
A. S191D has reduced current compared to Kir3.4* control or S191A. B. Both S185A and
S185D have reduced currents compared to Kir3.1* control. C. S196Q has reduced currents
compared to Kir3.2* and S196E, which has a small decrease from Kir3.2* control. **, S196E
has a statistically significant increase over S196Q at p<0.05. *, p<0.05 compared to control
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Figure 3.4. Comparison of simulation results for S196Q and S196E in Kir3.2(E152D)
background. A. Simulation time-course for average distance per subunit for Arg201(CZ)/Gln-196(CD) and Arg-201(CZ)/Asp-228(CG). B. Time-course for Arg201(CZ)/Glu-196(CD) and Arg-201(CZ)/Asp-228(CG). C. 80 ns snapshot of MD simulation
depicting Gln-196, Arg-201, and Asp-228. Phe-192 is shown as a space-filling model. D. 80
ns snapshot depicting Glu-196, Arg-201, and Asp-228.
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Figure 3.5. SEP196 mimics the switch mechanism found in S196E. A. Timecourse for
Ser-196(CB)/Arg-201(CZ) and Arg-201(CZ)/Asp-228(CG). B. Timecourse for SEP196(P)/Arg-201(CZ) and Arg-201(CZ)/Asp-228(CG). C. 80 ns snapshot depicting Arg-201,
Ser-196, and Asp-228. D. 80 ns snapshot depicting Arg-201, SEP196, and Asp-228
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Figure 3.6. Intersubunit helix bundle crossing distance at F192 increases in S196E, but
not S196Q. A. Time-course for S196Q for A-B and C-D intersubunit minimal distances. B.
Time-course for S196E, showing increase in A-B distance. C. 80 ns snapshot showing F192
A-B distance in S196Q. Chain A is colored in red and chain B is colored in blue. D. 80 ns
snapshot for F192 A-B distance in S196E.
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Figure 3.7. Neutralization of R201 results in low currents with increased sensitivity to
PMA in Kir3.2*_D228N background. A. Kir3.2*_D228N has higher currents than Kir3.2*
control. B. Kir3.2*_R201A_D228N has reduced currents compared to Kir3.2*_D228N. **,
Kir3.2*_R201A_D228N has significantly higher currents than Kir3.2*_R201A at p<0.05. C.
PMA inhibition is increased in Kir3.2*_D228N_R201A compared to Kir3.2*_D228N control.
*, p<0.05 compared to control.
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Figure 3.8. Alkaline phosphatase (CIP) treatment of excised inside-out patches. A. AP
treatment of Kir3.2* reactivated by MgATP inhibits channel function, but is recovered by
MgATP. B. AP pretreatment of Kir3.2* results in higher PIP2-induced activation level at 5
uM DiC8-PIP2. C. Same experiment as B, but with 50 uM PIP2.
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Figure 3.9. Schematic of PKC inhibition depending on phosphorylation state of Ser-196
and salt-bridge formation with Arg-201. In PKC sensitive channels, Q196 or
dephosphorylated S196 cannot interact with R201, and is stabilized by D228. In PKC
insensitive channels, R201 interacts with E196 or phosphorylated S196, stabilizing the open
state of the helix bundle crossing gate.
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Chapter 4. PKC INHIBITION IN KIR3.2 IS DEPENDENT ON CHANNEL-PIP2
INTERACTIONS

4.1.

Introduction
PIP2 is a universal activator of inward rectifier Kir channels, and the Kir3 channel family

is no exception. In the absence of PIP2, there is no Kir3 channel activity, such that the channel is
in a persistently closed state. Inhibition of PIP2-dependent channels can occur by PIP 2
hydrolysis, brought about by Gq-coupled receptors, which activate phospholipase C (PLC). PIP2
hydrolysis reduces local levels of PIP2, requiring resynthesis, but also increases the concentration
of its byproducts, inositol trisphosphate (IP3) and diacylglycerol (DAG). While IP3 releases
intracellular calcium, membrane-localized DAG activates PKC. The mechanism of PKC
inhibition is unclear, but evidence suggests that the final common mediator is a reduction in
channel-PIP2 interactions.
Kir channel apparent affinity for PIP2 can be measured using a water-soluble analog
called DiC8-PIP2. The PIP2 dose response for different Kir channels can then be measured, as
well as the effect of individual point mutants. In this assay, the Kir2.1 channel has higher PIP2
affinity than the closely related Kir2.3 channel. The dose response is an indirect measurement,
however, and cannot rule out allosteric effects of mutations. One such allosteric site is Leu-222.
The L222I has a right-shifted PIP2 dose response is Kir2.1, just as the I223L has a left-shifted
dose response in Kir2.3 (Zhang et al., 1999). It is unclear how a simple leucine to isoleucine
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change, a relatively conservative mutation, can have such dramatic effects on PIP 2 apparent
affinity, although these residues are located very close to a critical structural element implicated
in PIP2-mediated gating, the CD-loop (Meng et al., 2012). Strictly speaking, measurements of
PIP2 dose-response rely on channel activity, and as such are not pure measurements of binding
affinity. We use the term apparent affinity to distinguish from actual binding affinity, which
would need to be measured biochemically.
Du and colleagues examined two Kir2 channels, one that is normally inhibited by PKC
(Kir2.3) and one that is not (Kir2.1). In the case of Kir2.3, the point mutation I223L which
increases apparent PIP2 affinity resulted in a loss of PKC inhibition. A separate mutation,
R312Q, reduces apparent PIP2 affinity in the Kir2.1 channel, likely by neutralizing a positive
PIP2-binding residue. The mutant channel Kir2.1R312Q gained PKC inhibition, whereas the
control was not inhibited (Du et al., 2004). These results suggested PKC inhibition could be a
matter of fine-tuning PIP2 affinity, and that PKC phosphorylation exerts a functional effect only
on channels with sufficiently reduced PIP2 affinity.
Turning to Kir3 channels, Keselman et al. demonstrated that PKC application to an
excised patch containing Kir3.1/3.4 channels shifts the dose-dependence of PIP2 for the channel
to the right. This indicates that after PKC phosphorylation, the channel has a lower apparent
PIP2 affinity (Keselman et al., 2007). We proceeded to test whether manipulations that increase
or decrease channel-PIP2 interactions can affect PKC inhibition in the homomeric Kir3.2
channel.
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4.2.

Results

4.2.1 PKC Inhibitor blocks PMA inhibition
We first set out to examine in homomeric Kir3.2 the impact of increasing or decreasing
channel-PIP2 interactions on PKC inhibition. We confirmed that PMA effects were due to PKC
activation by using the pan-PKC inhibitor Bis-indolylmaleimide II (called Bis), which has been
used in multiple studies concerning Kir channel inhibition (Du et al., 2004; Keselman et al.,
2007). As shown in Figure 4.1, both currents from Kir3.2_E152D and Kir3.4_E147D (a
homomeric mutant with the analogous mutation in Kir3.4) were inhibited by 300 nM PMA,
which was blocked by 5 uM Bis pretreatment.
4.2.1. Lowering PIP2 levels increases PMA inhibition
One puzzling result from our previous study was the relatively low inhibition of Kir3.2*
compared to either Kir3.1* or Kir3.4* (Figure 4.2A). We hypothesized that the low level of
PMA inhibition in Kir3.2* may be due to enhanced channel-PIP2 interactions, and proceeded to
lower PIP2 levels. Wortmannin treatment of oocytes at high micromolar concentrations is
commonly used to inhibit Type III PI4K (Balla et al., 2008). PI4K is critical for maintaining
PIP2 levels, as it phosphorylates phosphatidylinositol at the 4’ position, which is rapidly
converted to PIP2 by PIP5K. We observed that after wortmannin treatment, PMA inhibition of
Kir3.2* was significantly increased (from 23.6 +/- 2.3% before to 66 +/- 1.4% inhibition after,
Figure 4.2B).
Since Kir3.2* could be converted into a channel with increased sensitivity to PKC
inhibition by lowering PIP2, we sought to determine if the current-enhancing mutation E152D
works by increasing PIP2 affinity compared to Kir3.2 alone. We used Ci-VSP, a voltage-
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activated PIP2 5-phosphatase, to examine the kinetics and recovery of both Kir3.2* and Kir3.2
wildtype, a relative measure of channel-PIP2 affinity (An et al., 2012; Rodriguez-Menchaca et
al., 2012). We used a voltage protocol designed to activate Ci-VSP submaximally, whereby CiVSP is activated at +10 mV and current levels are monitored by brief pulses to -80 mV.
Recovery is analyzed by holding at -80 mV following a one minute +80 mV depolarization
protocol that fully inhibits channel current (Figure 4.3A). A single exponential function was fit
to the descending curve of Ci-VSP inhibition shown in Figure 4.3B, and the Tau of inhibition
was compared for Kir3.2* and Kir3.2 (Figure 4.3C). The Tau of inhibition of Kir3.2* (~8.0 s)
was significantly slower compared to Kir3.2 wildtype (~2.5 s) channels. Additionally, the
recovery of Kir3.2* was qualitatively faster than Kir3.2 wildtype (Figure 4.3D), but complex
kinetics prevented a simple tau analysis. These results for Kir3.2 wildtype channels, faster CiVSP inhibition and slower recovery, are consistent with a reduced PIP2 affinity compared to
Kir3.2* channels.
4.2.2. Increases in channel-PIP2 affinity reduces PKC inhibition
Since lowering PIP2 levels results in increased sensitivity to PMA inhibition, we also
tested whether increasing channel-PIP2 interactions would result in reduced sensitivity to PMA
inhibition. To do this, we utilized two mutations known to increase channel current and impact
apparent PIP2 affinity: D228N and I234L. The D228N mutation renders the Kir3.2 channel
insensitive to sodium activation (Inanobe et al., 2010; Rosenhouse-Dantsker et al., 2008; Zhang
et al., 1999), and the I234L mutation allosterically strengthens channel-PIP2 interactions in a
variety of Kir channels (Du et al., 2004; Zhang et al., 1999). We compared D228N and I234L
mutants in the Kir3.2* background, finding that I234L had the largest effect on current level
(~3.3-fold enhancement), shown in Figure 4.4A. Since the PMA inhibition of Kir3.2* was
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already low, we tested PMA inhibition of D228N and I234L in the wildtype background. Only
the I234L mutant had significantly reduced PMA inhibition compared to Kir3.2 control (21 +/2.8% for Kir3.2_I234L vs. 45.6 +/- 6% inhibition for Kir3.2 control), whereas Kir3.2 and D228N
inhibition were similar, summarized in Figure 4.4B. Importantly, the PMA inhibition of
Kir3.2_I234L was significantly higher (45.4 +/- 6.8%) in wortmannin treated oocytes, consistent
with a PIP2-dependent effect.
4.2.3. Neutralization of Ser-196 uncouples PKC inhibition from PIP2-dependence
We tested the Ser-196 mutants for PIP2 dependence as well using S196Q and S196E. As
shown in Figure 4.5A, wortmannin treatment led to significantly increased inhibition in Kir3.2*
(from 27 +/- 5.4% control to 63.9 +/- 3.5% wortmannin treated) and Kir3.2*_S196E (from 19.4
+/- 5.2% control to 53 +/- 2.9% wortmannin treated), but did not significantly affect the already
high inhibition of Kir3.2*_S196Q (from 54 +/- 4.2% control to 65 +/- 4.5% wortmannin treated).
In the wildtype Kir3.2_I234L background (Figure 4.5B), S196Q had significantly greater PMA
inhibition (61.8 +/- 1.9%) than either control (24.7 +/- 4.3%) or S196E (33.9 +/- 2.6%), similar
to wortmannin-treated Kir3.2_I234L_S196E (61.9+/- 1.9%). These results indicate that the PKC
inhibition of the S196Q mutation is unresponsive to changes in PIP2 levels. The similar PIP2
dependence of the S196E mutant and the Kir3.2 channel further provide functional evidence that
Ser-196 is likely phosphorylated in the oocytes, as the two residues are functionally equivalent.
4.3.

Discussion
These results partially recapitulate the findings of Du et al., further showing that PKC

inhibition is dependent on channel-PIP2 interactions and can be fine-tuned in Kir3.2 by
increasing or lowering ambient PIP2. Notably, the charge on Ser-196 can uncouple PKC
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inhibition from dependence on channel-PIP2 interactions. In the case of neutralizing S196Q,
increasing channel-PIP2 interactions with the I234L mutant is not sufficient to reduce PKC
inhibition, which is higher than Kir3.2_I324L control. S196E maintains a dependence on
channel-PIP2 interactions similar to wildtype, suggesting that phosphorylated Ser-196 is resistant
to PKC inhibition, but in a PIP2-dependent manner.
We propose a model that incorporates both PIP2 and the phosphorylation state of Ser-196
in PKC inhibition (see Figure 4.6). Kir3.2 is resistant to PKC inhibition in cases of high PIP2
and when Ser-196 is phosphorylated. When Ser-196 is not phosphorylated, as with the S196Q
mutant, then the channel is readily inhibited, even when PIP2 levels are high. Interestingly, this
requirement of Ser-196 phosphorylation seems unique to Kir3.2 in the Kir3 family, as similar
mutations in Kir3.1 and Kir3.4 resulted in diverse PKC inhibition phenotypes. The earlier data
from Kir3.4* presents the best case for Ser-191 phosphorylation involved in PKC inhibition, as
only the phosphomimetic S191D mutant had reduced currents and reduced PMA effect. It would
be interesting to see if lowering PIP2 levels would increase the inhibition of Ser-191 mutants as
well. One study looked at the PIP2 dependence of PKC inhibition in Kir3.4, finding that both a
PIP2-enhancing chimera and the point mutation Kir3.4_I229L reduced the extent of PKC
inhibition compared to Kir3.4* control (Zhang et al., 2004). This finding is consistent with our
study and the results of Du et al. in Kir2 channels (Du et al., 2004).
Characterization of exactly how channel-PIP2 interactions determine PKC inhibition will
necessitate the identification of residues directly phosphorylated by PKC. Early mutagenesis
studies identified a potential site in Kir2.3, T53, which is located right next to the critical PIP2binding motif RWR, responsible for salt bridge interactions with the 1’ phosphate of PIP 2 in
Kir2.2 and Kir3.2 channels. Kir2.1, a channel that is resistant to PKC inhibition, has an Ile at the
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corresponding position, but mutation to Thr could render the channel sensitive to PKC (Zhu et
al., 1999). The negatively charged phosphothreonine would likely have a significant impact on
PIP2 binding, perhaps by forming salt-bridge interactions with the nearby RWR motif. Evidence
of direct phosphorylation at Thr-53 has remained elusive, however. Additionally, the results of
Du et al. whereby reduction of channel-PIP2 interactions (i.e. the R312Q mutant) render the
Kir2.1 channel sensitive to PKC inhibition indicate that additional phosphorylation sites are
likely involved.
Some controversy exists in the literature as to whether PKC inhibition operates by
phosphorylating the channel directly or by causing a nonspecific reduction in PIP 2 levels.
Multiple studies have shown in excised patches that catalytic PKC treatment of Kir3 channels
results in a reduction in channel open probability (Brown et al., 2005; Mao et al., 2004; Nikolov
et al., 2004). PKC treatment of Kir3.1/3.4 channels resulted in a right-shift of the dosedependence of DiC8-PIP2 activation, indicating that the channel is likely to be directly regulated
by PKC. Examination of PIP2 levels measured by FRET of PH-PLC domains in HEK293 cells
found no effect of PMA on PIP2 levels but a robust effect of M1 receptor activation (Keselman et
al., 2007). A recent study in Xenopus oocytes implicated PMA activation of PKCII as a
mechanism of increasing PIP2 levels, rather than reducing them (Chen et al., 2011). In this case,
an increase in PIP2 levels would be expected to partially block PKC inhibition, instead of
facilitating it. Resolving whether Kir3 channels are regulated directly by PKC will probably
require reconstitution in purified systems, as with the Kir3.1 chimera or full-length Kir3.2
protein.
In the next chapter we will attempt to identify PKC phosphorylation sites in Kir3.2 by
utilizing purified protein and mass spectrometry. Once identified, the location of the PKC
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phosphorylation site(s) in the context of PIP2-interacting residues might help explain how PKC
inhibition couples to reductions in channel-PIP2 interactions.
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Figure 4.1. PMA perfusion inhibits homomeric Kir3.2(E152D) and Kir3.4(E147D)
currents in a PKC-dependent manner. A. Time course of PMA inhibition in control
Kir3.2(E152D). B. Time course of PMA inhibition in Kir3.2(E152D) after Bis pretreatment.
C. Time course of PMA inhibition in control Kir3.4(E147D). D. Time course of PMA
inhibition in Kir3.4(E147D) pretreated with Bis.
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Figure 4.2. Kir3.2* has lower PMA inhibition relative to Kir3.1* or Kir3.4*, which can
be increased by PIP2 depletion. A. Kir3.2* has significantly reduced PMA inhibition
compared to either Kir3.4* or Kir3.1*. B. Wortmannin pretreatment increases PMA inhibition
of Kir3.2*. *, p<0.05 compared to control.
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Figure 4.3. Kir3.2*(E152D) has slower Ci-VSP mediated inhibition and faster recovery
vs. Kir3.2 wildtype. A. Left, voltage protocols (in mV) used for inhibition (top) and
recovery (bottom). Right, sample inhibition traces for Kir3.2*(E152D) (top) and recovery
(bottom). B. Kir3.2*(E152D) displays faster current inhibition compared to Kir3.2 wildtype.
C. Tau of inhibition for Kir3.2* is significantly slower than wildtype. *,p<0.05 compared to
control. D. Kir3.2* has faster recovery than Kir3.2 wildtype at -80 mV.
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Figure 4.4. Kir3.2 currents are inhibited by PMA in a PIP2-dependent manner. A.
D228N and I234L mutants increase Kir3.2* current, as expected with an increase in PIP2
affinity. **, I234L has significantly higher current than D228N at p<0.05. B. Kir3.2_I234L
has reduced PMA inhibition compared to either Kir3.2_D228N or Kir3.2 wildtype control.
**, Wortmannin treated Kir3.2_I234L has significantly increased PMA inhibition compared
to Kir3.2_I23L control. *, p<0.05 compared to control.
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Figure 4.5. S196Q does not exhibit PIP2 dependence for PMA inhibition. A. Both
Kir3.2* and Kir3.2*_S196E have increased PMA inhibition after wortmannin treatment, but
Kir3.2*_S196Q does not. B. S196Q in Kir3.2_I234L background has significantly increased
currents compared to Kir3.2_I234L control, similar to Kir3.2_I234L_S196E after wortmannin
treatment. *, p<0.05 compared to control group.
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Figure 4.6. Model for PKC Inhibition of Kir3.2 depending on Ser-196 phosphorylation
state and PIP2 concentration. The functional effect of PKC phosphorylation is high
inhibition when Ser-196 is not phosphorylated. When Ser-196 is phosphorylated, engaging
Arg-201, and if PIP2 concentration is high, PKC inhibition is low. If PIP2 concentration is
low, PKC inhibition is high even if Ser-196 is phosphorylated. Presumably the PKC
phosphorylation site(s) conferring inhibition is located in the cytoplasmic domain, or at least
at a site different from Ser-196
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Chapter 5. CHARACTERIZATION AND FUNCTIONAL ROLE OF PKC-DEPENDENT
RESIDUES IN KIR3.2

5.1.

Introduction
Clearly, homomeric Kir3.2 is responsive to PMA inhibition in a PKC-dependent manner,

yet the phosphorylation sites of PKC on the channel remain unknown. Our data thus far indicate
that disruption of phosphorylation of Ser-196 could not occlude PMA inhibition, since the
S196Q mutant exhibited increased PMA inhibition. Furthermore, Kir3.2 sensitivity to PKC
inhibition can be modulated by increasing or decreasing ambient PIP2 levels. The mechanism of
how PKC phosphorylation can be modulated by PIP2 will require identification of the
phosphorylation sites in the context of Kir3.2 structure. Additionally, no studies to date have
identified Kir3.2 to be directly phosphorylated by PKC. We proceeded to purify the cytosolic
domain of Kir3.2 and see if PKC can phosphorylate the channel in vitro. Additionally, putative
phosphorylation sites in Kir3.2 were analyzed for their impact on PMA-mediated inhibition.
5.2.

Results

5.2.1. Kir3.2 is phosphorylated by PKC in vitro
The cytosolic domain of Kir3.2 has several PKC consensus sites in its primary sequence.
We examined the phosphorylation potential of Kir3.2 by using a phosphorylation search
algorithm, NetPhosK (Blom et al., 2004). The algorithm identified 11 potential serines and 12
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potential threonines for phosphorylation. We excluded two sites from further analysis due to
their extracelllular location. Further kinase-specific characterization of the remaining sites
indicates three potential sites that were not tested in Kir3.4* by Mao et al.: T51, T85, S326, and
S366 (Figure 5.1).
We first confirmed that purified PKC could phosphorylate the cytoplasmic domain of
Kir3.2. The Kir3.2 cytoplasmic domain is composed of an N-term/C-term concatemer and has
been previously crystallized (Inanobe et al., 2007; Inanobe et al., 2010), matching well to the
full-length Kir3.2 channel. The cytosolic domain, called Kir3.2NC, was tagged with a SUMOHis N-terminus, expressed in E. coli bacteria, and purified by nickel immobilized metal affinity
chromatography (IMAC, see Chapter 2: Methods). This protein was incubated with purified
PKC and ran on an SDS-PAGE gel stained with Pro-Q Diamond Phosphoprotein Gel Stain
(Rusinova et al., 2009). As shown in Figure 5.2A, the Kir3.2NC protein incubated with PKC
was significantly darker than the Kir3.2NC protein alone, indicating the presence of either
phosphoserine or phosphothreonine. Figure 5.2B shows the total protein by Coomassie colloidal
blue stain, which was similar, indicating the increased signal was from phosphorylation. We
used purified Histone III-S as a positive control, showing that the Histone III-S incubated with
PKC also had a higher phospho-signal.
Comparison of mass spectra of PKC-treated Kir3.2NC vs. untreated control identified a
phosphopeptide containing pSer-238. Ser-238 lies in a key region to affect PIP2-dependent
gating, the D strand. The nearby positively charged Arg-240 has been shown to reduce
channel-PIP2 interactions when the corresponding residue, Arg-228, is neutralized in Kir2.1
(Lopes et al., 2002).
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5.2.2. PMA Inhibition Screen of Kir3.2 Ser/Thr Residues
We tested S238A in the background of Kir3.2*_D228N_S196Q, which gave consistently
high PMA inhibition and expression. However, the S238A mutant showed strong inhibition by
PMA, similar to the control, shown in Figure 5.3. Currents of S238A were significantly reduced
compared to Kir3.2* control (data now shown), whereas Kir3.2*_S238D and Kir3.2*_S238E
had no detectable current. Two additional mutations tested in the Kir3.2*_D228N_S196Q
background, S366A and S388A, had significant PMA inhibition that was not different from the
control. The T51A and T364A mutants in the Kir3.2*_D228N_S196Q background also
exhibited high sensitivity to PMA inhibition (data not shown).
Additionally, we tested mutations at a PKA site previously identified in Kir3.4 (Treiber et
al., 2013), which corresponds to Thr-204 in Kir3.2 (Figure 5.4A). Unexpectedly, both T204A
(29.2 +/- 3.5%) and T204D (49.5 +/- 2.8%) mutations resulted in significantly increased PMA
inhibition compared to Kir3.2* alone (18.6 +/- 2.8%), shown in Figure 5.4C. T204D had
significantly higher PMA inhibition than either T204A or Kir3.2* control. Comparing the
current levels, T204D was significantly reduced (29.2 +/- 1.6%) compared to T204A (88.8 +/5.8%), which was similar to Kir3.2* control (Figure 5.4B).
5.3.

Discussion
The prevalence of PKC consensus sites in Kir3.2, as well as general phosphorylation sites

not specific to PKC, indicates the likelihood of multiple phosphorylation sites involved in
functional PKC inhibition. This study presents evidence for the first time that PKC
phosphorylates the Kir3.2 cytoplasmic domain. Importantly, this domain is a concatemer of the
N-term/C-term cytoplasmic domains, which has been crystallized in the presence and absence of
sodium (Inanobe et al., 2010). This cytoplasmic domain matches well with the full-length Kir3.2
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structure. Previously, in vitro phosphorylation with PKC has been observed with the isolated Cterminal domain of the Kir3.1 and Kir3.4 channels (Brown et al., 2005; Thomas et al., 2006), but
not the Kir3.2 channel, implying that N-terminal elements may be necessary for PKC
phosphorylation.
PKC phosphorylation of the cytoplasmic domain of Kir3.2 and subsequent mass
spectrometry identified Ser-238 as an in vitro PKC phosphorylation site. The S238A mutant was
significantly inhibited by PMA, to the same degree as the Kir3.2* control. We cannot rule out
Ser-238 as a potential site involved in PMA inhibition, as other phosphorylation sites may
compensate for loss of Ser-238. Normalized current levels suggest that Ser-238 may be
constitutively phosphorylated in Kir3.2 channels, as the neutralization mutant S238A had
significantly reduced currents. However, both phosphomimetic S238D and S238E mutants had
no detectable current in the Kir3.2* background, preventing further analysis.
Alignment of eukaryotic Kir channels indicates that the respective Ser residue is present
in Kir3.2, 3.3, and 3.4, but not Kir3.1. Additionally, Kir6.1 and Kir6.2 have a Ser and a Thr at
the same position. Ser-238 is located in the D strand, immediately adjacent to a key region
implicated in PIP2-mediated gating, the CD-loop, also the location of Asp-228 (the sodium
coordination site) and Ile-234 (mutation to Leu increases PIP2 affinity). The arginine in the
phosphorylation motif SxR, Arg-240, corresponds to Arg-228 in Kir2.1, and its mutation affects
PIP2 sensitivity in this channel.
We mutated a residue implicated in PKA mediated gating, Thr-204 (Treiber et al., 2013),
and found increased PMA sensitivity in the mutants. The phosphomimetic T204D in particular
gave reduced current levels and increased PMA inhibition, reminiscent of S196Q or R201A
mutants. It is possible that T204D could attract Arg-201 away from Ser-196, thus leading to the
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S196Q-like phenotype. The hydroxyl group of Thr-204 is located in close proximity (~3.8 Å) to
the C-Zeta atom of Arg-201, which contains the guanidinium group. The functional relevance of
T204A is not easily explained, but could reflect an allosteric effect on Arg-201 placement as
well. Thr-204 is conserved in all eukaryotic Kir channels, except for Kir7.1 which has a Ser at
the corresponding position. Although the analogous residue to Thr-204 has been characterized in
Kir3.4 channels (Treiber et al., 2013), the effect of PKA phosphorylation at this residue remains
untested in Kir3.2 channels. Additionally, this residue is a hotspot for phosphorylation in other
Kir channels, and is implicated in PKC activation of Kir6.2 (Light et al., 2000), rather than
inhibition. The proximity of this residue to PIP2-binding residues in the C-linker helix (i.e. the
KKR motif) is very intriguing and warrants further exploration.
In summary, we have shown for the first time direct in vitro phosphorylation of the
Kir3.2 cytoplasmic domain by PKC, and identified a potential PKC-sensitive phosphorylation
site Ser-238 by mass spectrometry. This serine lies next to a key region implicated in PIP2mediated gating, the CD-loop, and is two residues away from a residue putatively involved in
channel-PIP2 interactions, Arg-240. In addition, we examined how a putative PKA site
identified in Kir3.4 channels affects PKC inhibition, finding that the charge on this residue can
allosterically regulate inhibition. Allosteric regulation at this site supports the idea that residues
near the helix bundle crossing can couple to PKC-dependent inhibition, likely by engaging in a
molecular tug of war for the crucial Arg-201.
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Figure 5.1. Primary sequence of mouse Kir3.2 with consensus phosphorylation sites.
Bold: predicted phosphorylation sites; underline: predicted PKC sites; gray background:
tested in Kir3.4*; red: not accessible (extracellular).
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Figure 5.2. Phosphorylation of Kir3.2 cytosolic domain by purified PKC. A.
Phosphoprotein stain of Histone control and Kir3.2NC. B. Coomassie stain of same gel
indicating total protein.
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Figure 5.3. PMA Inhibition of Kir3.2*_D228N_S196Q phosphosite mutants. S238A,
S366A, and S388A all demonstrated significant PMA inhibition.
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Figure 5.4. Effect of T204 mutations on current and PMA inhibition. A. Location of
T204 from Kir3.2/PIP2 crystal structure (PDB code 3SYA) in relation to R201 and PIP2. B.
Normalized currents for Kir3.2*, T204A, and T204D. C. PMA inhibition of Kir3.2*, T204A,
and T204D. *, p<0.05 compared to control group. **, T204D is significantly increased
compared to T204A at p<0.05.
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Chapter 6. CONCLUDING REMARKS

We set out to determine how PKC phosphorylation of a particular residue in a Kir
channel couples to the end goal of inhibition, hypothesizing that a reduction in channel-PIP2
interactions would accomplish this goal. We mutated residues thought to be targets of PKC
phosphorylation in Kir3.1/3.4 with the intent of investigating these mutations for their impact on
channel-PIP2 interactions. Immediately it became clear that the mutagenesis approach to blindly
identifying PKC sites can lead to erroneous conclusions. In the context of Kir3.1* and Kir3.4*,
there is a discrepancy between the PMA inhibition of Ser-to-Ala mutants and Ser-to-Asp
mutants, while neither residue can be phosphorylated. On the other hand, Kir3.2* residues
display the opposite paradigm: the phosphomimetic Ser-to-Glu acts like the wildtype, while the
neutral Ser-to-Gln increases PMA inhibition. This study shows that specific point mutations can
have far-reaching effects on gating and allosteric coupling to PKC inhibition.
It is prudent, then, to address this problem in multiple ways, which is why we pursued a
mass spectrometry approach to identify phosphorylation sites directly from the in vitro
phosphorylated cytoplasmic domain of Kir3.2. This project could be extended to the full-length
Kir3.2, which would provide PKC with a more physiological target; alternatively, the
phosphorylation of heterologously expressed Kir3.2 could be investigated using
immunoprecipitation techniques coupled with mass spectrometry, by comparing before and after
PMA or PKC treatment.
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After identification of the phosphorylation site(s) and subsequent mutagenesis to confirm
their relevance, we can use atomistic MD simulations to identify changes in salt-bridge and
hydrogen bonding networks that would likely occur after phosphorylation. This iterative
approach should prove useful in identifying the impact of phosphorylation of membrane proteins
for which a crystal structure is available, or a suitable homology model.
Perhaps most intriguingly, this study raises the possibility that Kir3.2 is phosphorylated at
a residue (Ser-196) interposed between two of the gating elements, the helix bundle crossing gate
and the G-loop gate. It would be useful to have a phospho-antibody to this residue in order to
investigate its phosphorylation state in native systems. Given the close proximity of Ser-196 to
the plasma membrane, it is possible that Ser-196 is constitutively phosphorylated prior to
tetrameric assembly, perhaps in the ER or Golgi. The access of phosphatases would be another
question, asking if dephosphorylation of Kir3.2 at this residue can increase their PKC sensitivity.
Finally, we turn to PIP2, which is absolutely necessary for channel activity. Mutations
which alter channel-PIP2 interactions have already been shown to underlie several known
channelopathies, with severe impact on constitutively active channels like Kir1.1 (Barrter) and
Kir2.1 (Andersen-Tawil). Some naturally occurring mutations are also thought to change
phosphorylation motifs in several ion channels, so-called phosphorylopathies (Gentile 2012).
Clearly, the regulation of channel function is complex and multifactorial, such that cases of low
PIP2 or high PIP2 levels can have a significant impact on the functional effect of
phosphorylation. Knowing how specific phosphorylation sites can affect channel-PIP2
interactions may lead to an important revelation for other PIP2-sensitive channels, of which the
list is continually expanding.
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Appendix 1. Mutations tested without detectable current
In Kir3.2* (E152D) Background:
S196D/C/F/G/R/L
Q197R
T317A
S232A/D/E
S326E
S238D/E
T85A
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